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ABSTRACT
In the first chapter, the determination of the correct sequence of the hydroxylase
genes from the M. capsulatus soluble methane monooxygenase (sMMO) system is
reported. This data was used in a comparison of all the sequenced members of
the sMMO system family of proteins. Sequence alignments of the a subunits
reveal absolutely conserved residues in the active site region that act as iron
ligands, participate in a hydrogen bonding network and provide a source of
protons in the largely hydrophobic substrate binding region. Further
examination of the rest of the conserved residues in the u. and P subunits reveal a
possible binding site for protein B, two possible binding sites for the reductase
and several regions of intersubunit contact. Possible models for the effects of
interaction between all the sMMO proteins are suggested based on the alignment
data.
The second chapter describes methodologies used in attempting to express the
sMMO hydroxylase. This protein forms insoluble, intractable inclusion bodies
upon expression in E. coli . The insoluble material was collected and subjected to
refolding procedures while varying temperature, reduction potential, thiol
concentration, protein concentration, and the identity of the denaturant.
Production of the inclusion bodies could not be averted via changing the nature
of the expression system by changing media conditions, E. coli strains, and
expression vector. Conclusions about the folding pathway of the sMMO
hydroxylase are drawn from the data collected. Possible future courses of action
to express the sMMO hydroxylase are suggested.
The third and final chapter describes the reaction of nitric oxide (NO) with the
reduced iron center in the sMMO hydroxylase. The majority of the iron centers
react with NO to form a dinitrosyl adduct, termed Hdi,,1, that models the Hperoxo
intermediate in the reaction of 02 with the reduced sMMO hydroxylase. This
reaction is characterized by M6ssbauer, EPR and optical spectroscopies using
both continuous and discontinuous kinetic techniques. The HudSYI intermediate
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forms whether protein B is present or not, in contrast to the Hperoxo intermediate
which forms in detectable amounts only in the presence of protein B. This is
interpreted in terms of changes in the open coordination sites in the reduced
sMMO diiron site upon protein B binding. The H yi, species decays to form a
complex mixture of products, including further reaction with NO to form
Fe(NO)2 units and reductive coupling of bound NO molecules to form N 2 0 and
oxidixed sMMO hydroxylase. The effects of protein B, methane and fluoride ion
on these reactions are investigated. In addition to formation of Hd,,i,l NO
reacts with a small percentage of sMMO hydroxylase sites that are depleted in
one iron to form an S=3/2 mononuclear iron-nitrosyl species.
Thesis Supervisor: Stephen J. Lippard
Title: Arthur Amos Noyes Professor of Chemistry
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Overview of the Soluble Methane Monooxygenase System
The soluble methane monooxygenase (sMMO) is a multicomponent enzyme
system that catalyzes the conversion of methane gas to liquid methanol, utilizing
oxygen as an oxidant and producing water as a byproduct, as depicted in eq. 1 (1-3).
The reaction takes place at a carboxylate-bridged non-heme diiron center located in
the MMO protein core.
MMO
CH 4 + NADH + H'+ 02 --- CH 30H + NAD* + H 2 0 (1)
This enzyme is one of a number of metalloproteins that perform biologically
essential transformations of small molecules, including nitrogenase (which reduces
nitrogen to ammonia) (4) and photosystem II (photosynthesis) (5). These types of
reactions are of tremendous current interest, due to both their novel and interesting
chemistry and our desire to
replicate these reactions in 2.- Glu 243
inexpensive small molecule Glu 114 H2
Fe(1)a%-.a
mimics for industrial
purposes. e(2)
Utility of the sMMO System His 147 His 246
The ethae toGlu 144The methane to MMO Iron Center in Fe(ll) Fe(H) oxidation state (6).
methanol reaction is currently
done industrially by using a variety of catalysts at high temperatures and pressures
in the gas phase. MMO can catalyze this reaction at room temperature and pressure
in water. It would be useful to use the method nature has devised, as methane gas is
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dangerous and expensive to transport to the refinery sites where the catalytic
transformation usually takes place. One can imagine small, easily transportable
biocatalyst plants set up at natural gas mines. At those plants, liquid methanol
would be produced and transported for further processing or distribution as fuel.
The MMO system also has other uses, as it is capable of oxidizing a wide
variety of other molecules. Trichloroethylene (TCE), a common ground water
pollutant and potent carcinogen, is rendered harmless by oxidation by MMO. TCE
was used extensively by both industry and the government as a degreasing solvent.
Used solvent was often left in waste containers that eventually developed leaks, or
was simply dumped in the ground. The pollutant has found its way into the ground
water drinking supply in several locations throughout the U.S., and cleanup via
traditional "pump-and-treat" techniques is very expensive. It is possible that either
biocatalysts based on the MMO system or microorganisms genetically engineered to
produce the MMO enzymes could be used to clean up TCE spills cheaply, as well as
other organic pollutants.
The sMMO Protein Components
The sMMO system consists of three proteins. The hydroxylase (H) contains
two copies each of three subunits, a, 0 and y. The a subunit is the location of the
non-heme diiron active site that is the site of dioxygen activation and of methane
hydroxylation. The reductase (R) contains a FAD, an [2Fe-2S] center and a NADH
binding site, and is responsible for accepting electrons from NADH and transferring
them to the hydroxylase. The third member of the sMMO system, the coupling
protein or protein B (B), is presumably a regulatory protein and modulates the
activity of the system depending upon the ratio of B to H.
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The sMMO Catalytic Cycle
The catalytic cycle as it is currently understood is as follows. The H0 ,
(diiron(II)) resting state of the hydroxylase is reduced to the diiron(II) (Hred)
oxidation level. Reaction with dioxygen produces the first well characterized
intermediate, Hperoxo (7, 8). This intermediate is assigned as a (g-1,2-
peroxo)diiron(III) species through spectroscopic comparison with
crystallographically characterized model compounds (9-11). The Hperoxo intermediate
spontaneously Hred Ie ~259s1
transforms into CH4
intermediate Q (8, Fe -4 em Hperoxo
12), which has iPem 2 2 1 .AFAD CH 4
CH 4  FAD+2H+ NADbeen assigned a R + H+
N DH
di(p- CH 4  ~0.45 s1
oxo)diiron(IV) em eM
structure based on HX IQi
EXAFS evidence CH3OH + H20 CH4
2H+
(13), although >~o.05 g1
other The sMMO Catalytic Cycle
interpretations of
the data are possible (1). Intermediate Q is widely assumed to be the active oxidant
that reacts with alkyl substrates to form hydroxylated products. Upon reaction, the
iron center returns to its resting, diferric state designated HOx.
The sMMO system catalyzes a kinetically difficult reaction that would be of
tremendous use to industry. A complete understanding of its structure and function
is not yet achieved. This thesis reports progress towards this goal.
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Chapter One
Sequencing and Analysis of the Methylococcus capsulatus (Bath)
Soluble Methane Monooxygenase Genes
Introduction
Non-heme carboxylate-bridged diiron centers have emerged as
widespread and chemically diverse units in proteins (1-5). The prototypical
members of this family of proteins are hemerythrin, ribonucleotide reductase R2
subunit (R2) and the soluble methane monooxygenase (sMMO) hydroxylase. A
hallmark of these cofactors is their reactivity with dioxygen. For example,
hemerythrin is a dioxygen transport protein, utilizing its iron center to reversibly
bind 02. The R2 subunit uses its iron center and one 02 molecule to generate a
tyrosine-based radical, which is subsequently used catalytically by the
ribonucleotide reductase R1 subunit to reduce ribonucleotides to
deoxyribonucleotides.
A common chemistry catalyzed by carboxylate-bridged diiron centers is
monooxygenase activity. This function is exemplified by the soluble methane
monooxygenase enzyme system (sMMO), the best studied member of this
subclass (3, 6-8). It catalyzes the oxidation of methane to methanol, utilizing
NADH as an electron source and releasing water as a byproduct. There are three
known proteins in the sMMO system. The hydroxylase (H) contains two copies
each of three subunits, a, [ and y, with the a subunits housing the diiron active
sites. The reductase (R) contains a FAD, an [2Fe-2S] center and a NADH binding
site, and is responsible for accepting electrons from NADH and transferring
them to the hydroxylase. The third member of the sMMO system, the coupling
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protein or protein B (B), is presumably a regulatory protein and modulates the
activity of the system depending upon the B:H (vide infra). The sMMO systems
from three different methylotrophs, Methylococcus capsulatus (Bath), Methylosinus
trichosporium OB3b OB3B and Methylocystis sp. strain M have been characterized,
and the proteins from the first two organisms are best understood. The structure
of the sMMO hydroxylase from M. capsulatus (Bath) as determined by X-ray
crystallography is shown in Figure 1-1, together with a schematic of the active
site residues (9-11). The most striking element of the tertiary structure is a large
canyon located in the center of the molecule formed by the a and P subunits.
The genes for the five polypeptides making up the three sMMO proteins
are arranged in one operon, along with an open reading frame, designated orfY,
for a heretofore unknown and unisolated protein (12-15). Figure 1-2 shows the
sMMO operon organization for all three organisms.
The role of the two ancillary proteins is of current interest, for the
chemistry (eq. 1) that takes place at the hydroxylase protein does not occur
MMO
CH 4 + NADH + H+ + 02 - CH 30H + NAD+ + H 2O (1)
without them. The reductase supplies electrons to the hydroxylase.
Characterizing the interactions between the reductase and the hydroxylase is
important to the general understanding of the system and may be of use in
designing industrially useful variants of the sMMOH. Protein B also plays an
important role. Without the presence of protein B, the hydroxylase reduces
dioxygen to water or hydrogen peroxide without concomitant oxidation of
substrate (16, 17). As the protein B:hydroxylase ratio is increased, the coupling of
dioxygen to substrate consumption increases. At a 1:1 ratio of protein
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B:hydroxylase, the system is fully coupled, and activity is optimal. Protein B has
an inhibitory effect when this ratio rises above 1. Understanding the effects of
protein B on the active site of the hydroxylase is crucial to the elucidation of the
mechanism; the structural consequences of B binding are unknown at this time.
The sMMO genes from all three organisms have been sequenced, but
several mistakes were made in the gene sequence of both the M. capsulatus (Bath)
and M. trichosporium OB3b operons. A base insertion that caused a frame shift
was found at the end of the M. capsulatus (Bath) mmoY during X-ray
crystallographic work on the enzyme (9). More recently, mass spectrometric
studies of the hydroxylase from M. capsulatus (Bath) disagreed with the
molecular mass predicted by the gene sequence (18). Many mistakes was found
in the M. trichosporium OB3b hydroxylase peptide sequence as a result of X-ray
crystallographic work (19).
There are several other monooxygenases that are quite similar to the
methane monooxygenases. The toluene monooxygenases (toluene-2-
monooxygenase (20), toluene-3-monooxygenase (21, 22) and toluene-4-
monooxygenase (23-26)) are capable of specifically hydroxylating toluene to the
corresponding o-, m- or p-cresol. Phenol hydroxylase (PH) from Pseudomonas sp.
CF600 catalyzes the hydroxylation of phenol and certain methyl- substituted
derivatives of phenol to catechol (27-30). The alkene monooxygenases (AMO) are
capable of epoxidizing various alkenes and alkynes, a reaction that the sMMOs
can also perform (31-34). All of these proteins have core similarities. They all
contain a hydroxylase protein with three subunits and a non-heme carboxylate-
bridged diiron center, a reductase and a coupling protein. They also catalyze
hydroxylation or epoxidation reactions by using dioxygen as an oxidant. The
operons for the phenol hydroxylase and toluene monooxygenase systems are
shown in Figure 1-3.
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Sequence analysis can be a useful tool in identifying residues that are
important in structure and function, especially when combined with
crystallographic information about the enzymes in question. There have been
several sequence analyses of the MMO proteins in the literature. One of the first
was a comparison of the protein sequence of the sMMOH, the structure of which
was then unknown, with that of the structurally characterized R2 subunit (35).
This remarkably prescient paper correctly deduced much of the detail of the
diiron active site of sMMO by comparison with R2. A second report compares
protein sequence data from several A-9 desaturases with those from several
ribonucleotide reductases and the soluble methane monooxygenase (36). This
alignment established that the desaturases were members of a carboxylate-
bridged diiron center family of proteins distinct from both the sMMO family of
monooxygenases and the ribonucleotide reductase R2 family. Homology
between the hydroxylase alpha subunits from the toluene-4-monooxygenase,
toluene-3-monooxygenase, toluene-2-monooxygenase, phenol hydroxylase,
alkene monooxygenase and sMMO systems has been helpful to establish that all
these proteins contain carboxylate-bridged diiron centers (21, 23, 37).
The reductase sequence from the sMMO family has been analyzed
extensively. It is a member of the FNR family of oxidoreductases, which include
ferredoxin-NADP' reductase (38) and phthalate dioxygenase reductase (39).
Sequence comparisons of the reductase proteins can be found in several places in
the literature (24, 40, 41). The coupling proteins have also been compared (42).
The sequence analyses thus far reported focus mainly on the diiron center,
its ligands, and the substrate binding region. No comparisons of the entire
protein sequences have appeared. Such a comparison of all of the proteins of the
multicomponent sMMO monooxygenase family would be of value in
determining which areas of the protein are essential for activity. Similarities
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between these proteins could provide important clues about structure, function
and relationships for this subclass of enzymes, including areas contributing to
interactions between the components. The docking site for protein B would be of
particular interest as a first step to understanding its ability to affect on the iron
active site.
Before the sequences can be compared, it is necessary to know that they
are correct. Crystallographic work on the hydroxylase indicated that the
published gene sequence was inaccurate.
This chapter reports the determination of the correct sequence of the M.
capsulatus (Bath) soluble methane monooxygenase hydroxylase and sequence
comparisons between the methane monooxygenases, alkene monooxygenases,
toluene monooxygenases and phenol hydroxylase. Possible roles for several of
the universally conserved residues are suggested based upon their locations in
the M. capsulatus (Bath) sMMOH structure.
Materials and Methods
DNA Sequencing. Sequenase 2.0 kits and enzymes were purchased from
United States Biochemicals. TEMED and 29:1 acrylamide:bis were purchased
from Biorad. Long RangerTM acrylamide was purchased from J. T. Baker and
a[32 P]dATP and C[3 5S]dATP from DuPont-NEN. All other chemicals were of the
highest quality available.
Oligonucleotide primers were either synthesized on a Cruachem or
Expedite DNA synthesizer or purchased from the MIT Biopolymers lab. All
oligonucleotides were PAGE-purified according to the Cruachem manufacturer's
instructions. Primer sequences are shown in Table 1-1, and the binding locations
of those primers relative to the sMMO operon genes are given in Figure 1-4.
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Plasmid DNA was purified by using Qiagen purification kits. Plasmid pCH4,
which contains a genomic clone of the sMMO operon from M. capsulatus (Bath),
was a gift from Prof. J. Colin Murrell (Warwick).
Plasmid DNA was sequenced by using the suggested protocol for double-
stranded DNA from USB, except that the sequence extension steps were carried
out at 45 *C. Both a[32P]dATP and a[35S]dATP were used in the sequencing
reactions; 8% 29:1 acrylamide:bis and 5% Long RangerTM gels were used in these
experiments.
Sequence Analysis. The Wisconsin GCG sequence analysis package
(version 7.3) was used to perform most of the sequence analysis (43). Initial
sequence alignment was made by using the GCG PileUp program with a gap
weight of 3 and a gap length weight of 0.1. Maligned (44) and BoxShade (45)
were used to generate protein homology plots. The M. capsulatus (Bath) sMMOH
oxidized Form I crystal structure was analyzed by using a combination of
Quanta97 (46) and MolScript 2.02 (47). A search profile of an alignment of the
three sMMO OrfY peptides was prepared by using the GCG ProfileMake
program. Both the GenEMBL (peptide-translated) and SwissProt databases
(release 107.0 with updates as of 7/20/98) were searched with the OrfY profile
with a gap weight of 4.5 and gap length weight of 0.05.
The DNA sequences used in this chapter were obtained from the
GenEMBL database on 7/20/98, through either the GCG Fetch program or the
world wide web Entrez interface at the National Center for Biotechnology
Information <http://www.ncbi.nlm.nih.gov/Entrez/nucleotide.html>. The
sequences and accession numbers used are as follows: Methylococcus capsulatus
(Bath) soluble methane monooxygenase (13, 14) (accession numbers M90050 and
M32314, NID g149833, EC 1.14.13.25), Methylosinus trichosporium OB3b OB3b
soluble methane monooxygenase (12) (accession number X55394, NID g44613,
24
EC 1.14.13.25), Methylocystis sp. strain M soluble methane monooxygenase (15)
(accession number U81594, NID g2098694, EC 1.14.13.25), Pseudomonas sp. strain
CF600 phenol hydroxylase (EC official name phenol-2-monooxygenase) (27)
(accession numbers M60276, M37764, M37775 and M57564, NID g151449, EC
1.14.13.7), Xanthobacter sp. strain Py2 alkene monooxygenase (48) (accession
number AJ006979, NID g3250923), Nocardia corallina B-276 alkene
monooxygenase (32) (accession number D37875, NID g529091), Pseudomonas
mendocina KR1 toluene-4-monooxygenase (23, 24) (accession numbers M65106
and M95045, NID's g151590 and g151596), Pseudomonas pickettii PKO1 toluene-3-
monooxygenase (21) (accession number U04052, NID g1590790), and
Pseudomonas sp. strain JS150 toluene/benzene-2-monooxygenase (20) (accession
number L40033, NID g1008895). Note that the sequences for the two AMO
systems are incomplete at this time. Only the a and p epoxygenase subunits,
reductase and coupling sequences are known for the N. corallina AMO; only the
epoxygenase a subunit sequence from Xanthobacter AMO has been reported.
Corrections to the M. trichosporium OB3b sMMO hydroxylase amino acid
sequence were applied as described (19). Corrections to the M. capsulatus (Bath)
sMMO protein sequences were applied as reported herein.
Results
Corrections to the sMMO gene sequences. The DNA sequences of the six
genes in the sMMO operon are shown in Figure 1-5, including the changes found
as a result of the sequencing described in this chapter. The errors found in the
published sequence are shown in Figure 1-6. Change A is a simple base pair
switch that alters residue Val84 of the a subunit to Glu. Change B is a double
frame shift that inserts a G at base pair 423 of mmoY and deletes a G at base pair
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434. The net result in the P peptide sequence is that four residues are altered.
Change C is a frame shift caused by the deletion of C at position 1086. This frame
shift alters the last 27 residues of the P subunit. Change D is a base pair inversion
in the mmoZ gene, changing residue H21 to Q and residue V22 to L.
An additional two changes to the M. capsulatus (Bath) sMMO operon have
been determined. An error in the sequence of protein B was discovered by amino
terminal sequencing, altering residue F12 to I (49). Electrospray mass
spectrometry (50), MALDI mass spectrometry (51) and DNA sequencing (52)
have confirmed this change, and that the protein sequence is otherwise correct.
An error in the mmoC gene was found recently by DNA sequencing (52). Both of
these errors are shown in Figure 1-7. Corrected DNA sequences for all of the
sMMO genes have been submitted to the GenEMBL gene database.
Changes to the M. trichosporium OB3b gene sequence as suggested by the
crystallographically determined electron density of the hydroxylase have also
been incorporated as part of the sequence alignment in this chapter (19). One of
the changes, D209E, is quite clearly correct from both a crystallographic and a
sequence alignment viewpoint, as that position is a glutamic acid in every other
sMMO family monooxygenase. Forty amino acid changes are made to the M.
trichosporium OB3b sequence, including a 26-residue stretch at the end of the p
subunit. Twenty of those alterations change the residue to its corresponding
residue in the M. capsulatus (Bath) sequence. The M. capsulatus (Bath) structure
was used as a starting model for the M. trichosporium OB3b enzyme structure
determination, due to problems encountered obtaining the phases. The
possibility therefore exists that the M. trichosporium OB3b model is biased. The
changes reported in the literature unfortunately were not confirmed by DNA
sequencing. For the purposes of this chapter, all of the changes made to the M.
trichosporium OB3b hydroxylase sequence are taken as correct, and many of them
26
probably are, but it is impossible to determine which are correct and which are
artifacts. Clearly, confirmation of the M. trichosporium OB3b sequence is needed.
Roles for genes from the sMMO family operons. The relationships between the
genes and gene products of the nine proteins examined in this chapter, M.
capsulatus (Bath) sMIMO, M. trichosporium OB3b sMMO, M. sp. strain M sMMO,
P. mendocina toluene-4-monooxygenase (T4M), P. pickettii PKO1 toluene-3-
monooxygenase (T3M), P. sp. toluene-2-monooxygenase (T2M), P. pudita phenol
hydroxylase (PH), N. corallina alkene monooxygenase (AMO) and Xanthobacter
sp. Py2 alkene monooxygenase, are shown in Figure 1-8. All of these systems
contain a hydroxylase that comprises three subunits. The homologies between
the sMMOHa analogues are all very high, and it is clear which genes correspond
to this important subunit. The same is true of the reductase and coupling protein
analogues. Although the sMMOP analogues all have homology to each other, in
some cases (dmpL, tbmB, tbuA2 and tmoE), they have higher homologies to the
mmoX genes of sMMO (20,21). With knowledge of the crystal structure of the
sMMO hydroxylase, this is understandable. Although the P subunit of the M.
capsulatus (Bath) hydroxylase is not homologous to the a subunit, they have
similar folding topologies (9). It is possible that a protein with sequence
homologous to sMMOHa might have a tertiary structure like that of the sMMOP
subunit, and would fulfill its function in the quaternary structure of the
hydroxylase. It seems likely that the P subunit is evolutionarily related to the a
subunit, and has retained structural aspects from its precursor. Note that the iron
binding ligands are not present in any of the P subunit analogues. The identity of
the y subunit in each hydroxylase is not clear from homology in many of the
cases. Because the P4 peptide of the phenol hydroxylase has been identified as
the y subunit in the hydroxylase of that system (28), and because its gene, dmpO,
is homologous to tbmE of the T2M system (35.3% identity between the two) (20),
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we can assign that role to those two proteins. Amino-terminal sequencing of the
purified hydroxylase from T4M indicates that the TmoB peptide is its third
subunit (25), and its homology with tbuU from T3M (38.8% identity) (20)
completes the set of known y analogues. The T3M and T4M systems both contain
a ferredoxin (ThuB and TmoC) with a Rieske-type [2Fe-2S] center, which is
necessary for turnover in the T4M system along with the reductase (25). This
ferredoxin is not present in the other systems. Finally, there is a gene of unknown
function in many of the systems: orfY in the sMMOs, dmpK in PH and tbmA in
T2M. There is homology between the orfYs in the sMMOs, and between dmpK
and tbmA. Interestingly, although the PH system is fully functional in vitro
without the dmpK gene product (PO), it is necessary in vivo for growth on phenol
(30). Note that the alkene monooxygenase operons are only partially sequenced.
The assignment of the AMO genes to functions in the AMO system is clear from
homology. Only the sMMOHx, sMMOHO, sMMOB and sMMOR homologies are
high enough to align the peptide sequences from all nine proteins.
Comparisons between the sMMO family protein sequences. Percent identity
and percent dissimilarity between MMOHx, MMOHO, MMOB and MMOR
analogues are shown in Figure 1-9. The proteins can be divided into three groups
that appear related: the sMMO systems, the T3M and T4M systems and the PH
and T2M systems. The N. corallina AMO hydroxylase is quite similar to the
sMMOH, but the reductase and coupling protein from that system are much
different from any of the other systems. Surprisingly, the Xanthobacter AMO
hydroxylase cc subunit is very different from its homologues.
Sequence alignments for the a and P subunits of the
hydroxylases/epoxidases, coupling proteins and reductases from the nine
enzyme systems are shown in Figures 1-10 through 1-13 respectively.
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Searchfor OrfY analogues. The three OrfY putative protein sequences from
the sMMO systems were aligned, and a search profile based on the consensus
sequence was prepared. Both a peptide-translated GenEMBL database and the
SwissProt protein database were searched by using this profile. The top
candidates were a putative RNA polymerase a factor in the Streptomyces coelicolor
rpoX operon, the E6 DNA-binding zinc-finger protein from Human
Papillomavirus type 30, insertion element IS402 from Pseudomonas cepacia and
Rattus norvegicus cortexin. None of these proteins exhibited significant homology
with the OrfY sequences.
The sA4MOHa analogues. The sequence alignment of the MMOHx
analogues is shown in Figure 1-10. Clearly, the MMOHx subunit has the most
homology to its counterparts in the other monooxygenases. The c subunit is
mostly comprised of a-helices. It is apparent that many of the identical residues
are spaced every 3-4 residues, indicating conservation of one side of an o-helix.
The MMOHx residues that are conserved absolutely between all the
proteins can be divided into four groups. The first group is a series of residues in
and around the active site of the enzyme. A view of the active site showing the
residues discussed here is shown in Figure 1-14. The iron ligands (E114, E144,
H147, E209, E243 and H246) are, of course, absolutely conserved. The iron ligand
residue sequence pattern E...EX2H has been noted to be a hallmark of proteins
containing carboxylate-bridged non-heme diiron centers (53), and is in fact the
only sequence that is conserved all across the sMMO, R2 and stearoyl-ACP
desaturase families (36).
The active site can be divided into two regions. The first lies above the
iron atoms as depicted in Figure 1-14, where there are few conserved residues.
The top side of the active site might be where substrates bind, and where the
monooxygenase chemistry takes place. This hypothesis is supported by a
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number of observations. In the R2 family, a closely related set of enzymes, this
side of the active site is where the tyrosine radical is located (54-56). The iron
ligands on this side of the iron site are quite mobile (10, 11); such lability might
indicate that this location is where dioxygen binds. Finally, the lack of conserved
residues in this area is to be expected if it is the site of substrate binding. A
phenol binding pocket is likely to be very different in size and shape from a
methane binding pocket. The only two conserved residues in this area are both
protic, T213 and N214. Threonine 213 is in a position homologous to a serine
residue in the R2 subunit thought to be responsible for proton flux into the active
site (57). Either one of these residues might assist in the delivery of protons
during the hydroxylation reaction.
The bottom half of the active site is, by contrast, quite well conserved. A
set of residues involved in hydrogen bonding between the F and C helices (D143,
R146, S238, D242 and R245) are absolutely conserved among all sMMO family
proteins. A schematic showing residues within hydrogen bonding distance of
one another is presented in Figure 1-15. These residues might be part of a
framework to hold the iron center in place, or possibly to deliver protons to the
active site. There are also two residues that are conserved for clear steric reasons.
Both A117 and G250 are located in positions where the packing is very tight, and
a larger residue would not fit. Glycine 250 in particular is located where helices E
and F come very close to one another. Finally, there is a triad of surface accessible
residues, comprising A224, G228 and D229, located at the turn between helices E
and F. It is possible that they form a "handle" on one end of the E/F helix half of
the active site. One of the ancillary proteins might interact with the "handle",
causing the E/F helices to shift, thereby altering the coordination environment at
the iron center.
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The conserved residues in other parts of the a subunit are shown in Figure
1-16. A group of aromatic residues located at the top of the hydroxylase (Y292,
W371, Y376) in close proximity to each other are shown in Figure 1-16 in red.
Along with those aromatics, a proline (P377) is absolutely conserved and may be
important structurally. This entire cluster of residues may be some kind of
docking site for another protein, or part of an electron transfer path. It has been
suggested that this area of the hydroxylase is the site where the reductase binds
(58).
Another set of residues is located in the second domain of the
hydroxylase, shown in white in Figure 1-16. They comprise residues P424, G443,
P461 and Y464. They are located slightly beneath the surface of the protein, near
the y subunit interface. No function for these residues is obvious. It is possible
that they are involved in interactions with the y subunit.
The fourth and final set of residues is located on the surface of the protein
in the "canyon" area, above the active site. This residue group comprises Y67,
K74, L321, G325, and P329, which can be seen in yellow in Figure 1-16. It has
been hypothesized that the canyon is a docking site for some other protein,
possibly protein B (9). These residues may be important in mediating the
interactions between the two proteins. In particular, K74 and Y67 are very close
to the surface and are located in the canyon. Combined with the E/F helix
"handle" described above, these residues might be key interaction points
between the coupling protein and the hydroxylase.
There are a number of residues that show up in the alignment that are
probably artifacts of the alignment algorithm, due to proximity to gaps and
isolation from other conserved residues. These residues are Y292, H344 and
G492.
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The sMMOH analogues. There is less identity in the MMOHP subunit
analogues than for the MMOHa subunit. It is therefore difficult to guess at the
function of any of the conserved residues, which for MMOH are shown in
white in Figure 1-17. They can be divided into three general areas. The first is at
the interface between the a and P subunits, and consists of D100, P101 and E185.
These residues might be important in intersubunit interactions, although there
are no conserved hydrogen bonding or salt bridge partners in the a subunit. A
second group of residues can be found under the surface of the $ subunit,
comprising W218, R228 and A331. The third group of residues, D240, E243, Q313
and W320, is very near the surface and consists of mostly polar residues. Lack of
knowledge about the function of the p subunit precludes making conclusions
about the functions of these residues. They might be involved in protein folding,
interactions with other ancillary proteins, or in electron transfer. Cross-linking
experiments in the M. trichosporium OB3b sMMO system indicate that the
reductase has a binding site on the f subunit (59). One or more of the conserved
areas listed above may be part of a reductase binding site.
The coupling protein analogues. There is little identity between the coupling
proteins from the sMMO family. The five absolutely conserved residues (V38,
E53, 179, G97, G144) are mapped in white onto the NMR structure of the P2
protein (42) from the phenol hydroxylase system in Figure 1-18. There are also a
number of closely homologous residues of interest near these absolutely
conserved residues, including I/V52, I/L85, D/E94, R/K98 and I/V107, shown
in yellow in Figure 1-18. The charged residues in this group might have partners
in the charged surface residues in the hydroxylase canyon. This idea is consistent
with cross-linking studies of the M. trichosporium OB3b sMMO system, where
protein B was shown to have a binding site on the a subunit of the hydroxylase
(59).
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The reductase analogues. Conserved residues in the reductase have been
discussed previously, as the sMMOR is a member of the FNR family of
oxidoreductases, which contain well-characterized [2Fe-2S] and FAD cofactor
sites and pockets for binding NADH (24, 38, 40). No reductase from a sMMO-
family multicomponent monooxygenase has yet been characterized
crystallographically. The T3M and T4M systems have electron delivery systems
that are different from the other seven. They contain ferredoxins that are
necessary for multiple turnover. Presumably, these ferredoxins ferry electrons
from the reductase to the hydroxylase, but such a function has not been shown
conclusively. If so, then identification of the reductase-hydroxylase interaction
region from this alignment is problematic, since the site does not exist in two of
the proteins.
Discussion
Proteins housing carboxylate-bridged non-heme diiron centers can be
divided into two structurally distinct classes, the hemerythrin-like class and
R2/sMMO-like class (36). The latter can be further divided into families of
proteins, including the R2, stearoyl-ACP desaturase and sMMO families. The
sMMO family has a number of distinguishing characteristics, including the
ability to catalyze hydroxylation/epoxidation chemistry, the presence of a three-
subunit hydroxylase that houses diiron centers in its a subunits, and the
presence of a coupling protein that is necessary for optimal activity. This chapter
compares the sequences of known members of this family in an effort to
determine which areas of the protein are important for its unique features.
Implications of the corrected M. capsulatus (Bath) DNA sequence. The
corrected sequence of the sMMO operon from M. capsulatus (Bath) presented
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here is consistent with the crystallographically-determined electron density for
the sMMO hydroxylase. All errors in the reported sequence can be easily
attributed to gel-reading errors or typographical mistakes. It can also explain
recent electrospray-ionization (ESI) mass spectrometric results (18), which were
clearly not consistent with the published sequence. The unexplained ESI data
obtained are listed in Table 1-2. Based on the mass spectrometric data obtained,
the authors correctly deduced the actual sequence of the P and y subunit,
although they could not distinguish between isoleucine and leucine. Due to
apparent misinterpretation of MS/MS sequencing of the u subunit peptides (data
not shown in the published MS work), however, they misidentified L82 as T82,
Q83 as R83 and failed to correct V84 to D84. These sequence changes, if correct,
would require several changes to the DNA sequence of the mmoX gene, and
these changes would be difficult to imagine as typographical errors. The
sequence as reported in Figure 1-6, however, is consistent with the electrospray
mass spectrometric data, clear from the cDNA sequencing and easy to imagine as
a simple typographical TA base inversion at base 251 of mmoX. Although mass
spectrometry is a useful tool, it is best used in concert with other complementary
techniques to obtain meaningful, clear results.
Sequence alignment of sMMOfamily proteins. Comparison of the x and
hydroxylase subunits, coupling proteins and reductases from the known sMMO
family proteins has revealed an interesting set of conserved residues. Much of
the data can be interpreted in light of what is known about the sMMO function
and structure.
Active site of the hydroxylase. A set of conserved residues corresponding to
the immediate area of the active site was identified in the sMMOHa subunit. The
residues comprised the iron ligands, a network of hydrogen bonds, a possible
proton delivery site, and sterically necessary conservations. The conserved
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residues were restricted to the area "below" the active site as it is usually drawn,
which is not surprising, given that the substrate is thought to bind "above" the
active site, and the proteins examined have very different substrates.
Understanding protein-protein interactions in sMMO. The structural and
functional effects of binding of the ancillary sMMO proteins, protein B and the
reductase, to the hydroxylase are important for understanding the mechanism of
methane oxidation. Determining how and where the reductase binds is crucial to
identifying the electron transfer pathway from the [2Fe-2S] site to the diiron
active site. Characterizing the effects of protein B is also critical. The
hydroxylation reaction does not occur without protein B, yet at high levels,
protein B inhibits the reaction. The binding of protein B must have a major effect
on the active site of the enzyme, without knowledge of which, an understanding
of the sMMO systems cannot be complete.
A possible protein B binding site was identified on the surface of the
hydroxylase canyon region. It is located just above the active site and could have
a direct effect on the four helix bundle that surrounds the diiron center. Part of
this binding site might include the residues A224, G228 and D229, which are
located at the bend where helix E and helix F meet, as depicted in Figure 1-14.
Crystallography reveals residues E209 and E243 to be the most mobile of all the
iron ligands, and they are located on helices E and F, respectively. Protein B
could affect the coordination of the active site irons through use of the E/F helix
turn as a "handle." Additionally, a set of residues that may be part of a binding
site at or near the surface of the canyon was identified as depicted in Figure 1-16.
A set of aromatic residues where the electron transfer pathway might
begin was also identified at the top of the hydroxylase molecule. The location of
these residues is consistent with a model placing the reductase binding site on
the top of the c subunit. Another possible binding site for the reductase was
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located on the surface of the P subunit. Two possible models of the binding sites
of the ancillary sMMO proteins are shown in Figure 1-19.
The sequence alignments described in this chapter provide information
about functionally essential areas of the sMMO proteins. These areas are obvious
targets for mutagenesis. The proposed binding sites for the reductase and
coupling proteins are particularly attractive in this regard. Initial studies in this
vein might involve mutating individual residues in the proposed binding sites
and measuring the effects on protein-protein interactions, electron transfer or
hydroxylase activity.
Many of the areas that are well conserved in the sMMO family have
obscure functionality. Perhaps as more is learned about the structure and
function of these interesting and useful protein systems, the functions of these
residues will be understood.
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Table 1-1. sMMO Hydroxylase Sequencing Primer Names and Binding
Locations.
41
D12344 sense mmoX 236-255
D12345 antisense mmoX 1304-1323
D12346 antisense mmoX 1126-1145
D12347 antisense mmoX 1018-1037
D12348 antisense mmoX 552-571
D12351 sense mmoX 722-741
D123453 sense mmoX 497-516
D12354 antisense mmoX 737-756
D12355 sense mmoX 1014-1033
seqO1 sense mmoY 351-370
seq02 sense mmoY 701-720
seq03 antisense mmoY 781-800
seq04 antisense mmoY 431-450
seq05 sense mmoZ 251-270
seq06 antisense mmoZ 251-270
seg07 antisense mmoX 236-255
seq08 sense mmoX 1304-1323
seq09 sense mmoX 1505-1524
seq1O antisense mmoY 41-60
seq11 antisense mmoY 190-209
seq12 sense mmoY 421-480
seql4 sense mmoY 1116-1135
seq15 antisense mmoZ 26-45
seq16 sense mmoZ 461-480
seql9 sense mmoZ 434-453
seq2O antisense mmoY 912-931
Table 1-1
Primer Name Direction BaseLocation
Table 1-2. Electrospray-Ionization Mass Spectrometric Results. Taken from
Buzy et al. (18). Only selected results that exhibited differences from the
expected, published sequence are shown. The amino-terminal methionine was
cleaved off in all cases. All results can be explained by the revised sequence as
described herein. The a' refers to a subunit that is cleaved between T7 and K8,
and the a" refers to a subunit cleaved between A9 and A10. The aT3a, (T2, JCB8
and yT4 peptides are cyanogen bromide/trypsin cleavage products; the
parenthetical numbers identify the residue range that they cover. These peptides
cover the areas of the sMMOH peptides that were not consistent with the
published sequence.
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Molecular Mass (Daltons)
Expected A ExpectedA
Sample Measured Average Mass red - Average M d measured
fromPubishd epeced) from Corrected (easurted)Sequence Sequence
a 60518.3 ± 5.8 60499.42 18.88 60515.38 2.92
a' 59973.9 ± 8.4 59954.81 19.09 59970.77 3.13
a" 59774.9 ± 6.0 59755.56 19.34 59771.52 3.38
(38a 1235.2 ±0.3 1219.41 15.79 1235.36 -0.16
s 45001.7 ±2.1 44590.18 411.52 45001.73 -0.03
(141-146) 792.4 0.2 666.71 125.69 792.85 -0.45
(337-end) 5913.7 0.3 5628.31 285.39 5913.73 -0.03
y 19715.6 ± 0.9 19710.52 5.08 19715.54 0.06
(1826) 1029.5 ± 0.5 1024.19 5.31 1029.20 0.30
(D
Figure 1-1. Methylococcus capsulatus (Bath) sMMO Hydroxylase Structure. a.
Structure of the Methylococcus capsulatus (Bath) sMMO hydroxylase (crystal form
I, diferric state) (9). The a-subunits are shown in purple, the 1-subunits are in
aqua, and the y-subunits are in green. The iron atoms are colored green, and one
of the two protomers is partially transparent to emphasize the location of the iron
center within the a subunit. The canyon is visible between the two a subunits.
This Figure was prepared by using MolScript (47). b. Structure of the active site,
showing all ligands, including protein residues, a hydroxide bridge, a terminal
water and an exogenous acetate bridge.
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Figure 1-1
Figure 1-2. Organization of the sMMO operons from three different
organisms. Gene arrangement is identical between the organisms.
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Methylococcus capsulatus (Bath)
mmoX
1584 bp
mmoY
1170 bp
mmoB mmoZ orfY
426 bp 513bp 312 bp
mmoC
1047 bp
Methylosinus trichosporium OB3B
mmoX
1578 bp
Methylocystis sp. Strain M
mmoX
1581 bp
mmoY
1188 bp
V
mmoY
1188 bp
mmoB mmoZ orfY mmoC
417 bp 510 bp 336 bp 1032 bp
mmoB mmoZ orfY mmoC
417 bp 510 bp 336 bp 1032 bp
I'
1 0 -::: ::
Figure 1-3. Organization of other sMMO family multicomponent
monooxygenase operons. The gene arrangement is quite different from the
sMMO operons and from each other. The alkene monooxygenases are not
included, as neither of them are fully sequenced.
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Pseudomonas pudita (strain CF600) Phenol Hydroxylase Operon
dmp dmpL d M dmpN
279 bp 996 bp 273 bp 1554 bp
dmp
360 bp
Pseudomonas sp. Strain JS150 Toluene/Benzene-2-Monooxygenase Operon
tb A tbmB tbmC tbmD tbmE
210 bp 1011 bp 270 bp 1542 bp 366 bp
Pseudomonas
Pseudomonas
t
15
pickettii PKO1 Toluene-3-Monooxygenase Operon
tbuAl tbuU tbuB tbuV tbuA2 tbuC
1506 bp 261 bp 336 bp 315 bp 990 bp 1005 bp
mendocina KR1 Toluene-4-Mo ooxygenase Operon
noA tmoB tmoC tmoD tmoE tmoF
03 bp 255 bp 339 bp 312 bp 984 bp 978 bp
V
dmpP
1063 bp
V
tbmF
1068 bp
CD1
Figure 1-4. Binding locations of primers used in sequencing the M. capsulatus
(Bath) sMMO hydroxylase genes. Primers beginning with a D were the gift of
Thanos Salifoglou.
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D12348t
D12354
seq1O
seq11
seq04
seq20
seq03
seq07t
seq09
D12344
D123453
D12351
D123455
seq08
seq15
seq06
seqOl
seq12
I
0
N
D12347t
D12346
D12345t
seq05
C
seq19
seq16
seqO2
lid
seql4
Figure 1-5. DNA sequences and deduced peptide sequences of the M.
capsulatus (Bath) sMMO genes. The hydroxylase, protein B, and reductase
genes can be found in the GenEMBL database. All errors in the original sequence
as listed in Figures 1-6 and 1-7 are incorporated in this listing.
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M. capsulatus (Bath) mmoX sequence
10 30 50
ATGGCACTTAGCACCGCAACCAAGGCCGCGACGGACGCGCTGGCTGCCAATCGGGCACCC
MetAlaLeuSerThrAlaThrLysAlaAlaThrAspAlaLeuAlaAlaAsnArgAlaPro
1
70 90 110
ACCAGCGTGAATGCACAGGAAGTGCACCGTTGGCTCCAGAGCTTCAACTGGGATTTCAAG
ThrSerValAsnAlaGlnGluValHisArgTrpLeuGlnSerPheAsnTrpAspPheLys
21
130 150 170
AACAACCGGACCAAGTACGCCACCAAGTACAAGATGGCGAACGAGACCAAGGAACAGTTC
AsnAsnArgThrLysTyrAlaThrLysTyrLysMetAlaAsnGluThrLysGluGlnPhe
41
190 210 230
AAGCTGATCGCCAAGGAATATGCGCGCATGGAGGCAGTCAAGGACGAAAGGCAGTTCGGT
LysLeuIleAlaLysGluTyrAlaArgMetGluAlaValLysAspGluArgGlnPheGly
61
250 270 290
AGCCTGCAGGATGCGCTGACCCGCCTCAACGCCGGTGTTCGCGTTCATCCGAAGTGGAAC
SerLeuGlnAspAlaLeuThrArgLeuAsnAlaGlyValArgValHisProLysTrpAsn
81
310 330 350
GAGACCATGAAAGTGGTTTCGAACTTCCTGGAAGTGGGCGAATACAACGCCATCGCCGCT
GluThrMetLysValValSerAsnPheLeuGluValGlyGluTyrAsnAlaIleAlaAla
101
370 390 410
ACCGGGATGCTGTGGGATTCCGCCCAGGCGGCGGAACAGAAGAACGGCTATCTGGCCCAG
ThrGlyMetLeuTrpAspSerAlaGlnAlaAlaGluGlnLysAsnGlyTyrLeuAlaGln
121
430 450 470
GTGTTGGATGAAATCCGCCACACCCACCAGTGTGCCTACGTCAACTACTACTTCGCGAAG
ValLeuAspGluIleArgHisThrHisGlnCysAlaTyrValAsnTyrTyrPheAlaLys
141
54
AACGGCCAGGACCCGGCCGGTCACAACGATGCTCGCCGCACCCGTACCATCGGTCCGCTG
AsnGlyGlnAspProAlaGlyHisAsnAspAlaArgArgThrArgThrIleGlyProLeu
161
550 570 590
TGGAAGGGCATGAAGCGCGTGTTTTCCGACGGCTTCATTTCCGGCGACGCCGTGGAATGC
TrpLysGlyMetLysArgValPheSerAspGlyPheIleSerGlyAspAlaValGluCys
181
610 630 650
TCCCTCAACCTGCAGCTGGTGGGTGAGGCCTGCTTCACCAATCCGCTGATCGTCGCAGTG
SerLeuAsnLeuGlnLeuValGlyGluAlaCysPheThrAsnProLeuIleValAlaVal
201
670 690 710
ACCGAATGGGCTGCCGCCAACGGCGATGAAATCACCCCGACGGTGTTCCTGTCGATCGAG
ThrGluTrpAlaAlaAlaAsnGlyAspGluIleThrProThrValPheLeuSerIleGlu
221
730 750 770
ACCGACGAACTGCGCCACATGGCCAACGGTTACCAGACCGTCGTTTCCATCGCCAACGAT
ThrAspGluLeuArgHisMetAlaAsnGlyTyrGlnThrValValSerIleAlaAsnAsp
241
790 810 830
CCGGCTTCCGCCAAGTATCTCAACACGGACCTGAACAACGCCTTCTGGACCCAGCAGAAG
ProAlaSerAlaLysTyrLeuAsnThrAspLeuAsnAsnAlaPheTrpThrGlnGlnLys
261
850 870 890
TACTTCACGCCGGTGTTGGGCATGCTGTTCGAGTATGGCTCCAAGTTCAAGGTCGAGCCG
TyrPheThrProValLeuGlyMetLeuPheGluTyrGlySerLysPheLysValGluPro
281
910 930 950
TGGGTCAAGACGTGGAACCGCTGGGTGTACGAGGACTGGGGCGGCATCTGGATCGGCCGT
TrpValLysThrTrpAsnArgTrpValTyrGluAspTrpGlyGlyIleTrpIleGlyArg
301
55
490 510 530
CTGGGCAAGTACGGGGTGGAGTCGCCGCGCAGCCTCAAGGACGCCAAGCAGGACGCTTAC
LeuGlyLysTyrGlyValGluSerProArgSerLeuLysAspAlaLysGlnAspAlaTyr
321
1030 1050 1070
TGGGCTCACCACGACCTGTATCTGCTGGCTTATGCGCTGTGGCCGACCGGCTTCTTCCGT
TrpAlaHisHisAspLeuTyrLeuLeuAlaTyrAlaLeuTrpProThrGlyPhePheArg
341
1090 1110 1130
CTGGCGCTGCCGGATCAGGAAGAAATGGAGTGGTTCGAGGCCAACTACCCCGGCTGGTAC
LeuAlaLeuProAspGlnGluGluMetGluTrpPheGluAlaAsnTyrProGlyTrpTyr
361
1150 1170 1190
GACCACTACGGCAAGATCTACGAGGAATGGCGCGCCCGCGGTTGCGAGGATCCGTCCTCG
AspHisTyrGlyLysIleTyrGluGluTrpArgAlaArgGlyCysGluAspProSerSer
381
1210 1230 1250
GGCTTCATCCCGCTGATGTGGTTCATCGAAAACAACCATCCCATCTACATCGATCGCGTG
GlyPheIleProLeuMetTrpPheIleGluAsnAsnHisProIleTyrIleAspArgVal
401
1270 1290 1310
TCGCAAGTGCCGTTCTGCCCGAGCTTGGCCAAGGGCGCCAGCACCCTGCGCGTGCACGAG
SerGlnValProPheCysProSerLeuAlaLysGlyAlaSerThrLeuArgValHisGlu
421
1330 1350 1370
TACAACGGCCAGATGCACACCTTCAGCGACCAGTGGGGCGAGCGCATGTGGCTGGCCGAG
TyrAsnGlyGlnMetHisThrPheSerAspGlnTrpGlyGluArgMetTrpLeuAlaGlu
441
1390 1410 1430
CCGGAGCGCTACGAGTGCCAGAACATCTTCGAACAGTACGAAGGACGCGAACTGTCGGAA
ProGluArgTyrGluCysGlnAsnIlePheGluGlnTyrGluGlyArgGluLeuSerGlu
461
56
970 990 1010
GTGATCGCCGAACTGCACGGGCTGCGCAGTGATGGCAAGACCCTGATCGCCCAGCCGCAT
ValIleAlaGluLeuHisGlyLeuArgSerAspGlyLysThrLeuIleAlaGlnProHis
481
1510 1530 1550
GTCCGTGGCGACAAGCTGTGGACGTTGGACGATATCAAACGCCTGAACTGCGTCTTCAAG
ValArgGlyAspLysLeuTrpThrLeuAspAspIleLysArgLeuAsnCysValPheLys
501
1570
AACCCGGTGAAGGCATTCAATTGA
AsnProValLysAlaPheAsnEnd
521
57
1450 1470 1490
M. capsulatus (Bath) mmoY sequence
10 30 50
ATGAGCATGTTAGGAGAAAGACGCCGCGGTCTGACCGATCCGGAAATGGCGGCCGTCATT
MetSerMetLeuGlyGluArgArgArgGlyLeuThrAspProGluMetAlaAlaValIle
1
70 90 110
TTGAAGGCGCTTCCTGAAGCTCCGCTGGACGGCAACAACAAGATGGGTTATTTCGTCACC
LeuLysAlaLeuProGluAlaProLeuAspGlyAsnAsnLysMetGlyTyrPheValThr
21
130 150 170
CCCCGCTGGAAACGCTTGACGGAATATGAAGCCCTGACCGTTTATGCGCAGCCCAACGCC
ProArgTrpLysArgLeuThrGluTyrGluAlaLeuThrValTyrAlaGlnProAsnAla
41
190 210 230
GACTGGATCGCCGGCGGCCTGGACTGGGGCGACTGGACCCAGAAATTCCACGGCGGCCGC
AspTrpIleAlaGlyGlyLeuAspTrpGlyAspTrpThrGlnLysPheHisGlyGlyArg
61
250 270 290
CCTTCCTGGGGCAACGAGACCACGGAGCTGCGCACCGTCGACTGGTTCAAGCACCGTGAC
ProSerTrpGlyAsnGluThrThrGluLeuArgThrValAspTrpPheLysHisArgAsp
81
310 330 350
CCGCTCCGCCGTTGGCATGCGCCGTACGTCAAGGACAAGGCCGAGGAATGGCGCTACACC
ProLeuArgArgTrpHisAlaProTyrValLysAspLysAlaGluGluTrpArgTyrThr
101
370 390 410
GACCGCTTCCTGCAGGGTTACTCCGCCGACGGTCAGATCCGGGCGATGAACCCGACCTGG
AspArgPheLeuGlnGlyTyrSerAlaAspGlyGlnIleArgAlaMetAsnProThrTrp
121
430 450 470
CGGGACGAGTTCATCAACCGGTATTGGGGCGCCTTCCTGTTCAACGAATACGGATTGTTC
ArgAspGluPheIleAsnArgTyrTrpGlyAlaPheLeuPheAsnGluTyrGlyLeuPhe
141
58
AACGCTCATTCGCAGGGCGCCCGGGAGGCGCTGTCGGACGTAACCCGCGTCAGCCTGGCT
AsnAlaHisSerGlnGlyAlaArgGluAlaLeuSerAspValThrArgValSerLeuAla
161
550 570 590
TTCTGGGGCTTCGACAAGATCGACATCGCCCAGATGATCCAACTCGAACGGGGTTTCCTC
PheTrpGlyPheAspLysIleAspIleAlaGlnMetIleGlnLeuGluArgGlyPheLeu
181
610 630 650
GCCAAGATCGTACCCGGTTTCGACGAGTCCACAGCGGTGCCGAAGGCCGAATGGACGAAC
AlaLysIleValProGlyPheAspGluSerThrAlaValProLysAlaGluTrpThrAsn
201
670 690 710
GGGGAGGTCTACAAGAGCGCCCGTCTGGCCGTGGAAGGGCTGTGGCAGGAGGTGTTCGAC
GlyGluValTyrLysSerAlaArgLeuAlaValGluGlyLeuTrpGlnGluValPheAsp
221
730 750 770
TGGAACGAGAGCGCTTTCTCGGTGCACGCCGTCTATGACGCGCTGTTCGGTCAGTTCGTC
TrpAsnGluSerAlaPheSerValHisAlaValTyrAspAlaLeuPheGlyGlnPheVal
241
790 810 830
CGCCGCGAGTTCTTTCAGCGGCTGGCTCCCCGCTTCGGCGACAATCTGACGCCATTCTTC
ArgArgGluPhePheGlnArgLeuAlaProArgPheGlyAspAsnLeuThrProPhePhe
261
850 870 890
ATCAACCAGGCCCAGACATACTTCCAGATCGCCAAGCAGGGCGTACAGGATCTGTATTAC
IleAsnGlnAlaGlnThrTyrPheGlnIleAlaLysGlnGlyValGlnAspLeuTyrTyr
281
910 930 950
AACTGTCTGGGTGACGATCCGGAGTTCAGCGATTACAACCGTACCGTGATGCGCAACTGG
AsnCysLeuGlyAspAspProGluPheSerAspTyrAsnArgThrValMetArgAsnTrp
301
59
490 510 530
ACCGGCAAGTGGCTGGAGCCCACGATCGCCGCTCTGCGCGACTTCATGGGGCTGTTTGCG
ThrGlyLysTrpLeuGluProThrIleAlaAlaLeuArgAspPheMetGlyLeuPheAla
321
1030 1050 1070
AAGCTGCCGGCGGGCACCACTGACAAGGAAGAAATCACCGCGTCCCTGTACCGGGTGGTC
LysLeuProAlaGlyThrThrAspLysGluGluIleThrAlaSerLeuTyrArgValVal
341
1090 1110 1130
GACGACTGGATCGAGGACTACGCCAGCAGGATCGACTTCAAGGCGGACCGCGATCAGATC
AspAspTrpIleGluAspTyrAlaSerArgIleAspPheLysAlaAspArgAspGlnIle
361
1150 1170
GTTAAAGCGGTTCTGGCAGGATTGAAATAA
ValLysAlaValLeuAlaGlyLeuLysEnd
381
60
970 990 1010
M. capsulatus (Bath) mmoB sequence
10 30 50
ATGAGCGTAAACAGCAACGCATACGACGCCGGCATCATGGGCCTGAAAGGCAAGGACTTC
MetSerValAsnSerAsnAlaTyrAspAlaGlyIleMetGlyLeuLysGlyLysAspPhe
1
70 90 110
GCCGATCAGTTCTTTGCCGACGAAAACCAAGTGGTCCATGAAAGCGACACGGTCGTTCTG
AlaAspGlnPhePheAlaAspGluAsnGlnValValHisGluSerAspThrValValLeu
21
130 150 170
GTCCTCAAGAAGTCGGACGAGATCAATACCTTTATCGAGGAGATCCTTCTGACGGACTAC
ValLeuLysLysSerAspGluIleAsnThrPheIleGluGluIleLeuLeuThrAspTyr
41
190 210 230
AAGAAGAACGTCAATCCGACGGTAAACGTGGAAGACCGCGCGGGTTACTGGTGGATCAAG
LysLysAsnValAsnProThrValAsnValGluAspArgAlaGlyTyrTrpTrpIleLys
61
250 270 290
GCCAACGGCAAGATCGAGGTCGATTGCGACGAGATTTCCGAGCTGTTGGGGCGGCAGTTC
AlaAsnGlyLysIleGluValAspCysAspGluIleSerGluLeuLeuGlyArgGlnPhe
81
310 330 350
AACGTCTACGACTTCCTCGTCGACGTTTCCTCCACCATCGGCCGGGCCTATACCCTGGGC
AsnValTyrAspPheLeuValAspValSerSerThrIleGlyArgAlaTyrThrLeuGly
101
370 390 410
AACAAGTTCACCATTACCAGTGAGCTGATGGGCCTGGACCGCAAGCTCGAAGACTATCAC
AsnLysPheThrIleThrSerGluLeuMetGlyLeuAspArgLysLeuGluAspTyrHis
121
GCTTAA
AlaEnd
141
61
M. capsulatus (Bath) mmoZ sequence
10 30 50
ATGGCGAAACTGGGTATACACAGCAACGACACCCGCGACGCCTGGGTGAACAAGATCGCG
MetAlaLysLeuGlyIleHisSerAsnAspThrArgAspAlaTrpValAsnLysIleAla
1
70 90 110
CAGCTCAACACCCTGGAAAAAGCGGCCGAGATGCTGAAGCAGTTCCGGATGGACCACACC
GlnLeuAsnThrLeuGluLysAlaAlaGluMetLeuLysGlnPheArgMetAspHisThr
21
130 150 170
ACGCCGTTCCGCAACAGCTACGAACTGGACAACGACTACCTCTGGATCGAGGCCAAGCTC
ThrProPheArgAsnSerTyrGluLeuAspAsnAspTyrLeuTrpIleGluAlaLysLeu
41
190 210 230
GAAGAGAAGGTCGCCGTCCTCAAGGCACGCGCCTTCAACGAGGTGGACTTCCGTCATAAG
GluGluLysValAlaValLeuLysAlaArgAlaPheAsnGluValAspPheArgHisLys
61
250 270 290
ACCGCTTTCGGCGAGGATGCCAAGTCCGTTCTGGACGGCACCGTCGCGAAGATGAACGCG
ThrAlaPheGlyGluAspAlaLysSerValLeuAspGlyThrValAlaLysMetAsnAla
81
310 330 350
GCCAAGGACAAGTGGGAGGCGGAGAAGATCCATATCGGTTTCCGCCAGGCCTACAAGCCG
AlaLysAspLysTrpGluAlaGluLysIleHisIleGlyPheArgGlnAlaTyrLysPro
101
370 390 410
CCGATCATGCCGGTGAACTATTTCCTGGACGGCGAGCGTCAGTTGGGGACCCGGCTGATG
ProIleMetProValAsnTyrPheLeuAspGlyGluArgGlnLeuGlyThrArgLeuMet
121
430 450 470
GAACTGCGCAACCTCAACTACTACGACACGCCGCTGGAAGAACTGCGCAAACAGCGCGGT
GluLeuArgAsnLeuAsnTyrTyrAspThrProLeuGluGluLeuArgLysGlnArgGly
141
62
490
GTGCGGGTGGTGCATCTGCAGTCGCCGCACTGA
ValArgValValHisLeuGlnSerProHisEnd
161
63
510
M. capsulatus (Bath) orfY sequence
10 30 50
ATGGTCGAATCGGCATTTCAGCCATTTTCGGGCGACGCAGACGAATGGTTCGAGGAACCA
MetValGluSerAlaPheGlnProPheSerGlyAspAlaAspGluTrpPheGluGluPro
1
70 90 110
CGGCCCCAGGCCGGTTTCTTCCCTTCCGCGGACTGGCATCTGCTCAAACGGGACGAGACC
ArgProGlnAlaGlyPhePheProSerAlaAspTrpHisLeuLeuLysArgAspGluThr
21
130 150 170
TACGCAGCCTATGCCAAGGATCTCGATTTCATGTGGCGGTGGGTCATCGTCCGGGAAGAA
TyrAlaAlaTyrAlaLysAspLeuAspPheMetTrpArgTrpValIleValArgGluGlu
41
190 210 230
AGGATCGTCCAGGAGGGTTGCTCGATCAGCCTGGAGTCGTCGATCCGCGCCGTGACGCAC
ArgIleValGlnGluGlyCysSerIleSerLeuGluSerSerIleArgAlaValThrHis
61
250 270 290
GTACTGAATTATTTTGGTATGACCGAACAACGCGCCCCGGCAGAGGACCGGACCGGCGGA
ValLeuAsnTyrPheGlyMetThrGluGlnArgAlaProAlaGluAspArgThrGlyGly
81
310
GTTCAACATTGA
ValGlnHisEnd
101
64
M. capsulatus (Bath) mmoC sequence
10 30 50
ATGCAGCGAGTTCACACTATCACGGCGGTGACGGAGGATGGCGAATCGCTCCGCTTCGAA
MetGlnArgValHisThrIleThrAlaValThrGluAspGlyGluSerLeuArgPheGlu
1
70 90 110
TGCCGTTCGGACGAGGACGTCATCACCGCCGCCCTGCGCCAGAACATCTTTCTGATGTCG
CysArgSerAspGluAspValIleThrAlaAlaLeuArgGlnAsnIlePheLeuMetSer
21
130 150 170
TCCTGCCGGGAGGGCGGCTGTGCGACCTGCAAGGCCTTGTGCAGCGAAGGGGACTACGAC
SerCysArgGluGlyGlyCysAlaThrCysLysAlaLeuCysSerGluGlyAspTyrAsp
41
190 210 230
CTCAAGGGCTGCAGCGTTCAGGCGCTGCCGCCGGAAGAGGAGGAGGAAGGGTTGGTGTTG
LeuLysGlyCysSerValGlnAlaLeuProProGluGluGluGluGluGlyLeuValLeu
61
250 270 290
TTGTGCCGGACCTACCCGAAGACCGACCTGGAAATCGAACTGCCCTATACCCATTGCCGC
LeuCysArgThrTyrProLysThrAspLeuGluIleGluLeuProTyrThrHisCysArg
81
310 330 350
ATCAGTTTTGGTGAGGTCGGCAGTTTCGAGGCGGAGGTCGTCGGCCTCAACTGGGTTTCG
IleSerPheGlyGluValGlySerPheGluAlaGluValValGlyLeuAsnTrpValSer
101
370 390 410
AGCAACACCGTCCAGTTTCTTTTGCAGAAGCGGCCCGACGAGTGCGGCAACCGTGGCGTG
SerAsnThrValGlnPheLeuLeuGlnLysArgProAspGluCysGlyAsnArgGlyVal
121
430 450 470
AAATTCGAACCCGGTCAGTTCATGGACCTGACCATCCCCGGCACCGATGTCTCCCGCTCC
LysPheGluProGlyGlnPheMetAspLeuThrIleProGlyThrAspValSerArgSer
141
65
TACTCGCCGGCGAACCTTCCTAATCCCGAAGGCCGCCTGGAGTTCCTGATCCGCGTGTTA
TyrSerProAlaAsnLeuProAsnProGluGlyArgLeuGluPheLeuIleArgValLeu
161
550 570 590
CCGGAGGGACGGTTTTCGGACTACCTGCGCAATGACGCGCGTGTCGGACAGGTCCTCTCG
ProGluGlyArgPheSerAspTyrLeuArgAsnAspAlaArgValGlyGlnValLeuSer
181
610 630 650
GTCAAAGGGCCACTGGGCGTGTTCGGTCTCAAGGAGCGGGGCATGGCGCCGCGCTATTTC
ValLysGlyProLeuGlyValPheGlyLeuLysGluArgGlyMetAlaProArgTyrPhe
201
670 690 710
GTGGCCGGCGGCACCGGGTTGGCGCCGGTGGTCTCGATGGTGCGGCAGATGCAGGAGTGG
ValAlaGlyGlyThrGlyLeuAlaProValValSerMetValArgGlnMetGlnGluTrp
221
730 750 770
ACCGCGCCGAACGAGACCCGCATCTATTTCGGTGTGAACACCGAGCCGGAATTGTTCTAC
ThrAlaProAsnGluThrArgIleTyrPheGlyValAsnThrGluProGluLeuPheTyr
241
790 810 830
ATCGACGAGCTCAAATCCCTGGAACGATCGATGCGCAATCTCACCGTGAAGGCCTGTGTC
IleAspGluLeuLysSerLeuGluArgSerMetArgAsnLeuThrValLysAlaCysVal
261
850 870 890
TGGCACCCGAGCGGGGACTGGGAAGGCGAGCAGGGCTCGCCCATCGATGCGTTGCGGGAA
TrpHisProSerGlyAspTrpGluGlyGluGlnGlySerProIleAspAlaLeuArgGlu
281
910 930 950
GACCTGGAGTCCTCCGACGCCAACCCGGACATTTATTTGTGCGGTCCGCCGGGCATGATC
AspLeuGluSerSerAspAlaAsnProAspIleTyrLeuCysGlyProProGlyMetIle
301
66
490 510 530
GATGCCGCCTGCGAGCTGGTACGCAGCCGCGGTATCCCCGGCGAACAGGTCTTCTTCGAA
AspAlaAlaCysGluLeuValArgSerArgGlyIleProGlyGluGlnValPhePheGlu
321
1030
AAATTCCTGCCGTCCGGGGCGGCCTGA
LysPheLeuProSerGlyAlaAlaEnd
341
67
970 990 1010
Figure 1-6. Mistakes in the published hydroxylase subunit gene sequences and
their corrections. Changes are shown in bold face. All mistakes were confirmed
by DNA sequencing.
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mmoX Correction A
Liturature Gene Sequence
Liturature Protein Sequence
Corrected Gene Sequence
Corrected Protein Sequence
251
CTG CAG GTA GCG CTG
Leu Gln Val Ala Leu
CTG CAG GAT GCG CTG
Leu Gln Asp Ala Leu
mmoY Correction B
424
Liturature Gene Sequence TGG CGG ACG AGT
Liturature Protein Sequence Trp Arg Thr Ser
Corrected Gene Sequence TGG CGG GAC GAG
Corrected Protein Sequence Trp Arg Asp Glu
434
TCA TGC AAC CCG
Ser Cys Asn Arg
TTC ATC AAC CCG
Phe Ile Asn Arg
mmoY Correction C
Liturature Gene Sequence
Liturature Protein Sequence
Corrected Gene Sequence
Corrected Protein Sequence
1086
GAC GAT GGA 69 bp
Asp Asp Gly 23 res
GAC GAC TGG 69 bp
Asp Asp Trp 23 res
1164 1170
GAT TGA
Asp End
GGA TTG AAA TAA
Gly Leu Lys End
mmoZ Correction D
Liturature Gene Sequence
Liturature Protein Sequence
Corrected Gene Sequence
Corrected Protein Sequence
63 64
ATC GCG CAC GTC AAC ACC
Ile Ala His Val Asn Thr
ATC GCG CAG CTC AAC ACC
Ile Ala Gln Leu Asn Thr
Figure 1-6
Figure 1-7. Mistakes found in the published DNA sequence for the sMMO
genes mmoB and mmoC. The mistake in the mmoB gene was discovered by N-
terminal sequencing of the protein B peptide (49) and confirmed via DNA
sequencing (52). The mistake in the mmoC gene was discovered by DNA
sequencing (52). Changes are shown in bold face.
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mmoB Correction E
Literature Gene Sequence
Literature Protein Sequence
Actual Gene Sequence
Actual Protein Sequence
34
GCC GGC TTC ATG GGC
Ala Gly Phe Met Gly
GCC GGC ATC ATG GGC
Ala Gly Ile Met Gly
mmoC Correction F
760
Literature Gene Sequence
Literature Protein Sequence
Corrected Gene Sequence
Corrected Protein Sequence
GTG AAC CAC GAG CCG
Val Trp His Glu Pro
GTG AAC ACC GAG CCG
Val Trp Thr Glu Pro
Figure 1-7
Figure 1-8. Relationships between the genes and proteins of the sMMO
multicomponent monooxygenase family. The T3M and T4M systems have
ferredoxins encoded in their operons, where the others do not. The gray
background behind the orfY homologues for T2M and PH indicate that sequence
alignments and homology analyses do not indicate that these proteins are related
to orfY. They are included in the orfY category because they are all small open
reading frames that have no similarities with any other genes in the GenEMBL
database.
72
liycroxylase
a subunit
Gene
Calc. MW
Methylococcus Methylosinus Methylocystis Pseudomonas Pseudomonas Pseudomonas Pseudomonas
capsulatus trichosporium sp. strain M pudita sp. strain JS105 pickettii mendocina Nocardia Xanthobacter
(Bath) OB3B strain CF600 PKOI KR1 corallina sp. Py2
Soluble Soluble Soluble Toluene/ Alkene Alkene
Methane Methane Methane Phenol Benzene-2- Toluene-3- Toluene-4- M Anlxyene M Anxyene
Monooxygenase Monooxygenase Monooxygenase Hydroxylase Monooxygenase Monooxygenase Monooxygenase Monooxygenase Monooxygenase
sMMOHa
mmoX
60646
sMMOHa
mmoX
60076
sMMOHa
mmoX
59973
P3
dmpN
60522
TbmD
tbmD
60077
ThuAl
tbuAl
57555
TmoA
tmoA
57982
AmoC
amoC
57212
Hydroxylase sMMOHO sMMOHO sMMOHP Pi TbmB TbuA2 TmoE AmoA1subunit
Gene mmoY mmoY mmoY dmpL tbmB tbuA2 tmoE amoA ?
Calc. MW 45132 45112 45170 38208 37042 37525 38386 38462
Hydroxylase sMMOHy sMMOHy sMMOHT P4 ThmE TbuU TmoB
,ysubunit
Gene mmoZ mmoZ mmoZ dmpO tbmE tbuU tmoB ? ?
Calc. MW 19847 19314 19349 13207 13001 9604 9588
Reductase sMMOR sMMOR sMMOR P5 ThmF ThuC TmoF AmoD
Gene mmoC mmoC mmoC dmpP tbmF tbuC tmoF amoD ?
Calc. MW 38541 37991 37358 38477 37990 36101 35983 37282
Ferredoxin TbuB TmoC
Gene tbuB tmoC
Calc. MW 12254 12326
Protein
Gene
Calc. MW
sMMOB
mmoB
15984
sMMOB
mmoB
14883
sMMOB
mmoB
14901
P2
dmpM
10491
TbmC
tbmC
10029
TbuV
tbuV
11703
TmoD
tmoD
11618
AmoB
amoB
12985
XamoA
xamoA
58040
orfY Product OrfY OrfY OrfY
Gene orlY orfY orJY
Calc. MW 11942 11926 12499
.. ..... .... ... .
..................... ................. ............... ..  -- ------------- .. .......................................  .....
Figure 1-9. Identity statistics between the closely related proteins of the sMMO
multicomponent monooxygenase family. These include the a and P subunits of
the hydroxylase, protein B and the reductase. Three numbers are given in each
comparison; the top is the number of identical residues, the middle is the number
of differing residues, and the bottom number is the number of gap placeholders.
Numbers right of the diagonal are percentages and left of the diagonal are raw
numbers. Percentages do not add up to 100% due to mismatches at the ends of
the peptides. Note that two randomly paired proteins would be expected to have
identity percentages of 10-15%, depending upon the size of the protein.
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Hydroxylase alpha subunit
1 2 3 4
526 96% 81% 34%
1 MtriHalpha 0 3% 18% 61%0 0% 0% 4%
506 526 82% 34%
2 MatMHalpha 20 0 17% 61%
0 0 0% 4%
428 434 527 34%
3 Mcap_Halpha 98 92 0 61%
1 1 0 4%
177 178 176 501
4 AMDAmoC 316 315 317 0
21 21 22 0
94 91 93 95
5 T2MTbmD 399 402 401 369
42 42 42 55
91 89 91 98
6 PHP3 394 396 395 358
50 50 50 63
95 94 96 85
7 T3MTbuAl 397 398 397 377
42 42 42 57
98 97 96 89
8 T4MTmoA 393 394 396 372
43 43 43 58
95 93 96 84
9 AMDXamoA 395 397 394 376
43 43 44 58
Coupling Protein
1 2 3 4
138 96% 65% 26%
1 MtriB 0 3% 32% 67%
0 0% 1% 5%
133 138 65% 26%
2 MspM_B 5 0 32% 67%
0 0 1% 5%
92 92 141 22%
3 Mcap_B 46 46 0 73%
2 2 0 4%
29 29 24 104
4 T3MTbuV 74 74 80 0
6 6 5 0
24 22 21 58
5 T4M_TMOD 78 80 82 45
7 7 6 1
22 21 18 31
6 T2MTbmC 66 67 71 58
8 8 7 3
19 18 20 24
7 PHP2 70 71 70 66
8 8 7 3
23 22 25 32
8 AMDAMoB 93 94 92 70
8 8 7 3
5 6 7 8
17% 17% 17% 18%
74% 73% 74% 73%
7% 9% 7% 8%
17% 16% 17% 18%
75% 74% 74% 73%
7% 9% 7% 8%
17% 16% 17% 17%
74% 73% 74% 74%
7% 9% 7% 8%
18% 18% 16% 17%
71% 68% 72% 71%
10% 12% 10% 11%
513 63% 21% 23%
0 34% 73% 71%
0 2% 5% 5%
325 517 20% 23%
178 0 73% 70%
12 0 5% 5%
109 107 501 66%
379 377 0 32%
29 29 0 0%
119 120 336 500
368 363 163 0
30 30 3 0
127 125 219 224
357 355 278 271
31 31 3 6
5
22%
71%
6%
20%
73%
6%
19%
75%
5%
55%
43%
0%
103
00
33
56
3
26
64
3
19
82
4
9
17%
74%
8%
17%
74%
8%
17%
73%
8%
16%
72%
11%
24%
69%
6%
24%
69%
6%
43%
55%
0%
44%
54%
1%
497
0
0
6 7 8
22% 19% 18%
68% 72% 75%
8% 8% 6%
21% 18% 17%
69% 73% 75%
8% 8% 6%
18% 20% 20%
73% 72% 74%
7% 7% 5%
33% 25% 30%
63% 70% 66%
3% 3% 2%
35% 27% 18%
60% 68% 78%
3% 3% 3%
89 48% 23%
0 51% 75%
0 0% 1%
43 90 21%
46 0 76%
0 0 1%
21 20 117
68 70 0
1 1 0
Hydroxylase beta subunit
1 2 3 4 5 6 7 8
395 94% 58% 25% 15% 13% 15% 17%
1 Mtri-Hbeta 0 5% 39% 65% 78% 81% 79% 75%
0 0% 1% 9% 5% 5% 4% 7%
372 395 60% 25% 16% 13% 15% 17%
2 MspM_Hbeta 23 0 38% 65% 77% 80% 79% 75%
0 0 1% 9% 5% 5% 4% 7%
232 237 389 25% 15% 11% 12% 13%
3 Mcap_Hbeta 157 152 0 66% 78% 81% 81% 78%
6 6 0 8% 6% 6% 5% 7%
95 97 94 343 18% 19% 14% 16%
4 AM0)_AMOA 248 246 249 0 72% 71% 75% 70%
34 34 32 0 9% 8% 10% 12%
55 57 53 64 329 56% 18% 19%
5 T3MTbuA2 270 268 270 245 0 42% 75% 74%
19 19 21 31 0 0% 5% 5%
45 46 41 65 186 327 18% 18%
6 T4M TmoE 278 277 280 243 140 0 75% 76%
20 20 22 30 2 0 5% 5%
54 55 45 49 63 62 336 42%
7 T2MTbmB 278 277 285 262 258 257 0 53%
17 17 19 37 19 20 0 3%
60 63 47 59 67 61 144 331
8 PH_Pl 267 264 278 246 250 255 182 0
25 25 27 44 19 18 13 0
Reductase
1 2 3 4 5 6 7 8
340 71% 41% 20% 18% 22% 22% 21%
1 MtriR 0 23% 51% 67% 68% 66% 65% 67%
0 5% 6% 11% 13% 10% 11% 10%
250 343 50% 24% 21% 26% 25% 26%
2 MspM_R 81 0 47% 66% 67% 64% 65% 64%
21 0 2% 9% 10% 8% 8% 8%
148 174 348 22% 25% 23% 25% 28%
3 Mcap_R 182 166 0 69% 64% 69% 65% 63%
24 7 0 8% 9% 7% 8% 7%
74 87 80 334 37% 29% 28% 30%
4 T3MTbuC 242 234 243 0 59% 68% 68% 65%
40 33 29 0 2% 2% 3% 4%
64 77 89 125 326 27% 28% 29%5 T4M_TmoF 243 236 226 199 0 67% 66% 63%
47 38 34 9 0 4% 5% 6%
80 96 83 99 94 355 55% 31%
6 T2M_TbmF 241 231 248 232 231 0 42% 64%
39 30 26 10 15 0 1% 3%
82 92 92 96 98 198 353 32%
7 PH_P2 236 232 235 232 224 153 0 63%
41 32 30 12 17 6 0 4%
77 94 101 103 102 110 114 342
8 AMtAmoD 241 230 226 222 218 228 221 0
39 30 28 16 21 13 15 0
Figure 1-9
Figure 1-10. Sequence alignments of the peptides corresponding to the (X
subunit of the hydroxylase. Residues conserved across all peptides are shown in
reverse. The top number in each bar is the consensus numbering, the bottom
number is the M. capsulatus (Bath) residue number. Residues belonging to helices
in domain 1 of the hydroxylase are marked.
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Mtri_Halpha
MstMHalpha
McapHalpha
AMO_AmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
MtriHalpha
MstMHalpha
Mcap_Halpha
AMO_AnoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMO XamoA
Mcap #
Mcap Helix
Mtri Halpha
MstMHalpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
Mcap Helix
MtriHalpha
MstM_Halpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
Mcap Helix
....... MAI
....... MAI
....... MAL
MDTRVAKKKL
MATH.NKKRL
....... MAL
....... MAM
....... MAL
51
NRTKYPTKYH
NRTKYATKYH
NRTKYATKYK
RRPKFETKYK
DWDKWQ ....
DWDKWE ....
TWETYD....
KWESYD ....
AWDDWD ....
SLATKAATDA
SLATKAATDA
STATKAATDA
GLKERYAAMT
NLKDKYRYLT
LERAAWYDIA
HPRKDWYELT
LNRDDWYDIA
MANETKEQFK
MANQTKEQFK
MANETKEQFK
MPKKGKDPFR
...... DPFR
...... DPFR
...... EPYK
...... EPYK
...... EPFR
LKVNRAPVGV
LKVNRAPVGV
LAANRAPTSV
....... MAS
RGLGWETTYQ
RDLAWETTYQ
RTTNWTPSYV
RATNWTPSYV
RDVDWTLSYV
VIAKE
VIAKE
LIAKE
VLIRD
LTMDA
LTMDT
TSYPE
TSYPE
VSFRE
RME
RME
RME
KME
KYQ
KYQ
SIQ
SIQ
VQ
67
EPQEVHKWLQ
EPQEVHKWLQ
NAQEVHRWLQ
NPTQLHEKSK
PMDKVFP..Y
KKEDVFP. . L
TESELFPDIM
TEEQLFPERM
DRAVAFPEEW
AA
AP
AV)
AE
GE
AE
RE
RE
RE
DERQFGT
DERQFGT
DERQFGS
DDRTHG.
EKKLYAV
EKKLYAI
DAGAYSV
DAGAYSV
EASVGAI
74
50
SFNWDFK. . E
SFNWDFK. . D
SFNWDFK. . N
SYDWDFTSVE
DTYEGIK.IH
EHFEGIK. IT
TGAQGVP .ME
SGHMGIP . LE
KGEKDIC. GT
100
LLDGLTRLGA
LLDGLTRLGA
LQDALTRLNA
FLDGAVRTRE
IEAFAQNNGQ
FDAFAQNNGH
KAALERSRMF
KAALERAKIY
REAMVRAKAY
[ ------- HELIX A--------
101
GNKVHPRWGE
GNKVHPRWGE
GVRVHPKWNE
ATRIEPRFAE
LGISDARYVN
QNISDARYVN
ED.ADPGWLS
EN.SDPGWIS
EK.LDDGHKA
TMKVISNFLE
TMKVISNFLE
TMKVVSNFLE
AMKIMVPQLT
ALKLFIQGVT
ALKLFLTAVS
ILKAHYGAIA
TLKSHYGAIA
TSHLHMGTIT
VI
VI
Vi
N,
P
L
Vi
M
1
Y IAAS
IAAS
Y IAAT
Y GC
YN RGF
Y FQGF
Y SAE
TGE
TMQ
14 117
AMLWDSATAA
AMLWDSATAA
GMLWDSAQAA
GMIISAVENQ
AHVGRQFTGE
SRVGRQFSGA
ARMARFGRAP
GRMARFSKAP
SRFVRFAPSA
[ ------------- HELIX B-
151
I THQC AFINHYYSKH
LEEHQC AFINHYYSKH
I THQC AYVNYYFAKN
QLE MTLRNYYAKH
I L YQTE T... HAISHY
I L QTQ V.. .HAMSHY
GQLQ LYFPHDYCAK
GQLQ LFFPHEYCKK
QLD LRFSHDLLND
143 147
HELIX C ----------]
YHDPAGHNDA RRTRAIGPLW
YHDPAGHNDA RRTRAIGPLW
GQDPAGHNDA RRTRTIGPLW
WCDPSGFDIG QRG ..... LY
NKYFNGMHSP NHWFDRVWYL
NKHFDGLHDF AHMYDRVWYL
DRQFDWAHKA YHTNEWG. .A
DRQFDWAWRA YHSNEWA. .A
SPSFDWSQRA FHTDEWA..V
150
EQKNGYLAQV
EQKNGYLAQV
EQKNGYLAQV
ELRQGYAAQM
GARVAAQMQS
GARVACQMQA
GMRNMATFGM
GNRNMATFGM
RWRSLGAFGM
[ ---------
200
KGMKRVFADG
KGMKRVFADG
KGMKRVFSDG
QHPAGLVS IG
SVPKSFFEDA
SVPKSYMDDA
IAARSTFDDL
IAAKHFFDDI
LATRNLFDDI
[ ---HELIX D-
Figure 1-10
MtriHalpha
MstM_Halpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PH P3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
Mcap Helix
MtriHalpha
MstM_Halpha
McapHalpha
AMO_AmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
Mcap Helix
MtriHalpha
MstM Halpha
Mcap_Halpha
AMO_AmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
Mcap Helix
Mtri_Halpha
MstMHalpha
McapHalpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
201
.... FISRDA
.... FISGDA
.... FISGDA
EFQHFNTGDP
....CTA.GP
....RTA.GP
.... FMSRSA
.... ITGRDA
.... MLNADC
250
VECSVNLQLV C PLI VAVTE SAN EITPTVFL
VECSVNLQLV C PLI VAVTE SAN EITPTVFL
VECSLNLQLV C PLI VAVTE N EITPTVFL
LDVIIDLNIV A ILL VATPQ AN AMASVFL
FEFLTAVSFS YV LLF VPFMS PHN STVTFGF
FEFLTAVSFS YV LLF VPFMS YN TVTFGF
IDIAIMLTFA G QF LGLAA EA FTFASLIS
ISVAIMLTFS G QF LGLAA EA YTFANLIS
VEAALATSLT G IQF VALAS EA NFSNLLS
209 214 224 229
------ ] [-----------HELIX E------------]
251
ET S A GQTV.VS
ET L A YQTV.VS
IET L A YQTV.VS
IQS A YGSV.MA
QS S T IECIKFM
Qs T EVIKFM
IQT S Q GPALQIL
IQT S Q GPALQLL
IQT Q FPTLDVM
38 242 246 250
HELIX F ------------- ]
301
GYLFE
GYLFE
GMLFE
GWCSE
AMMQD
GMMMD
GTSMD
GPVMD
GVSMD
GSKF
GSKF
GSKF
GARK
M..L
M..L
ATPL
YTPL
YTPV
292
-------
351
AKRDAYWAH
AKTDAYWAH
AKQDAYWAH
AADEVKWSH
ACEGKDHI S
TTIGKEHIT
MINEFDYQH
FLKDIDELH
FEKTLDHGH
..KVEPWVKT
..KVEPWVKT
..KVEPWVKT
..RPWSYKAQ
PKRVMSWKEA
PNKVMSWSEA
HHRKESFKE.
EDRSQSFKE.
AKRQMSFKE.
IANDPASAKF
IANDPAAAKY
IANDPASAKY
LLENEDNLPL
LEQDPDNVPI
LEQHEDNVPI
IASGRKEQA.
IENGKREEA.
MKHDPK.RA.
LNTDLNNAFW
LNTDLNNAFW
LNTDLNNAFW
LNQSLDRHFW
VQRWTDKWFW
IQRWIDKWFW
.QKLVDIAIA
.QKKVDMAIW
.QQILDVAFW
300
TQQKYFTPVL
TQQKYFTPAL
TQQKYFTPVL
RAHKALDNAV
RGYRLLTIV.
RGYRLLTLI.
RAWRLFSLLT
RAWRLFAVLT
RSYRIFQAVT
[ ------------- HELIX G
WNRWVSEDWG
WNRWVYEDWG
WNRWVYEDWG
WEEWVVDDFV
WE.MYAEGNG
WG.VYFEQAG
...FMTEWIV
...FMYEWII
...FMLEWIV
GIWIG GKY
GIWIG GKY
GIWIG GKY
GGYID SEF
GALFK RY
GALFK ERY
GQFERT IDL
GQFERS IDL
KHHERI RDY
321 325
VES
VES
VES
VQA
IRE
IRP
LDL
LD
LQF
350
RSLRD
RVLRD
RSLKD
CLGA
GWKD
YVEQ
YWDQ
YWDL
YWDT
329
[ ------- HELIX H-------]
DLALAAYAMW PLAFARLALP
DLALAAYALW PLAFARLALP
DLYLLAYALW PTGFFRLALP
TLGQVLSAVW PLNFWRSDAM
QAWATFYNYG RGRR.STRGS
QVWGALYQYS KATSFHTWIP
AYQMGIWFWR PTIWWNPAAG
SYHMGVLDWR TTAWWNPAAG
ALHIGTWFWR PTLFWDPNGG
344
.DEEDQP
.DEEDQE
.DQEEME
.GPADFE
.EREEMC
. GDEELN
ITPDCRE
VTPEERE
VSREERF
371
FE
FE
FE
FE
S
S
E
LE
LN
400
A G.WADH
A G.WADH
A G.WYDH
N G.WSAA
E ESFDTL
E DTFDKY
E .WNDT
E G.WNKR
Q .WEES
377
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2
MtriHalpha
MstMHalpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
MtriHalpha
MstMHalpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuA1
T4MTmoA
AMOXamoA
Mcap #
MtriHalpha
MstMHalpha
Mcap_Halpha
AMO_AmoC
T2MTbmD
PHP3
T3MTbuA1
T4MTmoA
AMOXamoA
Mcap #
MtriHalpha
MstMHalpha
Mcap_Halpha
AMOAmoC
T2MTbmD
PHP3
T3MTbuAl
T4MTmoA
AMOXamoA
Mcap #
401
YGKIFNEWKK
YGKIYNEWKK
YGKIYEEWRA
YQGYWEGYKA
YRPAFEFWAR
YRPRFEFWRE
FGKAWDVIID
WGRCWDVITE
WGVLWDEIIS
451
GTG.SLRVHE
GSG.SLRVHE
GAS.TLRVHE
NAA ... RIIE
ATKIAYRESD
PTKLSLRSLV
GWIVKDYPLD
DWNIEVFSLE
RFHLKPEQLV
501
EVIAEGHGVR
EVIAEGHGVR
EVIAELHGLR
DVIVDLGYIR
HCFPEGTDPT
NC ........
QIQP .. .. PN
QIQP .... MT
QIQP .... MT
LGYEDPKSGF
LGYEDPKSGF
RGCEDPSSGF
LA.. DPAGGR
R. .AEEGRRF
Q . .QAKGERF
NLLAGKPELT
NVLNDRMDLV
NINAGNIEKT
F'
FN
YN
FE
YE
HE
YB
HN
YB
SD
SD
SD
PD
AE
.E
LM
LE
IE
551
KKHSLTD
KKHSLTD
MHTFSD
KIALCS
KYHFCS
ERYQFCS
RTYHFNS
RLYHFGS
RLYTFDS
443
KTLIAQP
TLIAQP
TLIAQP
TLIGQP
FDPLMAV
DVETVV
LQYMNL
LKYMGF
LNWMGL
492
IPYQWLLANG
IPYAWLLENG
IPLMWFIENN
IMLQELPGLP
YN....... .K
YN....... D
VP ....... E
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Figure 1-11. Sequence alignments of the peptides corresponding to the P
subunit of the hydroxylase. Residues conserved across all peptides are shown in
reverse. The top number in each bar is the consensus numbering, the bottom
number is the M. capsulatus (Bath) residue number.
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Figure 1-12. Sequence alignments of the peptides corresponding to protein B.
Residues conserved across all peptides are shown in reverse. Residues with
conservative substitutions are shown with gray background. The top number in
each bar is the consensus numbering, the bottom numbers are the M. capsulatus
(Bath) sMMOB residue number and P. pudita P2 residue number.
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Figure 1-13. Sequence alignments of the peptides corresponding to the
reductase. Residues conserved across all peptides are shown in reverse. The top
number in each bar is the consensus numbering, the bottom number is the M.
capsulatus (Bath) residue number. Domains corresponding to [2Fe-2S], FAD and
NADH binding regions are marked (24).
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222
Figure 1-14. View of the absolutely conserved a subunit residues near the
active site of the M. capsulatus (Bath) sMMO hydroxylase. Carbons are marked
gray, oxygens are red, and nitrogens are blue. The four helices that surround the
active site are shown as partially transparent ribbons. The irons are shown in
pink, and iron 1 is marked as such. The hydroxide bridge, terminal water and
acetate bridge are all omitted for clarity. This Figure was generated by using the
program MolScript (47).
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Figure 1-14
Figure 1-15. Schematic of the hydrogen bonding network in the absolutely
conserved residues near the active site. Distances as shown in the Figure do not
necessarily correspond to actual distances.
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Figure 1-16. View of the absolutely conserved a subunit residues not near the
active site of the M. capsulatus (Bath) sMMO hydroxylase. All peptides but the
rightmost a subunit are partially transparent for clarity. Residues lining the
canyon are shown in yellow, the aromatic cluster residues on top of the
hydroxylase are in red, and the cluster of residues under the y subunit are shown
in white. This Figure was generated by using the program MolScript (47).
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Figure 1-16
Figure 1-17. View of the absolutely conserved P subunit residues in the M.
capsulatus (Bath) sMMO hydroxylase. All peptides but the rightmost P subunit
are partially transparent for clarity. Conserved residues are shown in white. This
Figure was generated by using the program MolScript (47).
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Figure 1-17
Figure 1-18. View of the absolutely conserved residues in the P. pudita CF600
phenol hydroxylase P2 protein (model 1). Conserved residues are shown in
white. Conservative substitutions are shown in yellow. This Figure was
generated by using the program MolScript (47).
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Figure 1-18
Figure 1-19. Cartoon of two possible sMMO family interprotein interactions.
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Chapter Two
Heterologous Expression of the Methylococcus capsulatus (Bath) Soluble Methane
Monooxygenase Hydroxylase
Introduction
Carbon atoms, along with other elements necessary for the chemistry of
life, circulate in the biosphere in a characteristic pattern. This pattern, termed the
carbon cycle, can be represented in a redox fashion as shown in eq. 1 below:
Respiration
CH ' CHOH 'CH 2O - CHOOH CO2  (1)
Photosynthesis
This equation shows the circulation of carbon between high oxidation states
(carbon dioxide in the atmosphere and carbonates in the hydro/geosphere) and
low oxidation states (methane in the atmosphere and petrochemicals in the
geosphere). The two most well known processes in the carbon cycle are labeled
in eq. 1. Photosynthesis is the process of storing solar energy in carbon by
reducing carbon dioxide to the formaldehyde oxidation state, generally in the
form of saccharides. Respiration is the release of that energy through the
oxidation of saccharides to carbon dioxide.
There are biological participants in the carbon cycle at all oxidation levels.
The metabolic oxidation of methane to carbon dioxide occurs in methylotrophic
bacteria (1-5). About half of the total organic matter degraded by anaerobic
microbes is converted to methane, but only 0.5% of this methane reaches the
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atmosphere (2). Most is consumed by methanotrophs. These organisms, some of
which are capable of subsisting on methane as a sole source of carbon and
energy, form a small but crucial ecological niche for recycling carbon from
decaying biomass. Figure 2-1 portrays a greatly simplified schematic of the role
methanotrophs play in the carbon cycle. Complex carbon molecules that are not
easily broken down settle in soil layers that are very low in oxygen. Heterotrophs
and methanogens anaerobically break down these complex molecules into
smaller and more reduced pieces. Methane gas is the ultimate product of this
process, for it can be neither disassociated into smaller pieces nor further
reduced. It diffuses upward into soil containing relatively high oxygen levels
where it is oxidized by methanotrophs to form either biomass or carbon dioxide.
Since this methane would otherwise reach the atmosphere where methane can
act as a greenhouse gas, methanotrophs occupy an important and interesting
niche in the carbon cycle.
Methanotrophs are capable of subsisting on nothing but methane and
oxygen for all of their carbon and energy. Methane metabolism in these
organisms is summarized in Figure 2-2. The first two steps, catalyzed by
methane monooxygenase (MMO) and methanol dehydrogenase, are energy
neutral, since the MMO reaction consumes NADH and the second step produces
a NADH equivalent. The organism then makes a choice between carbon fixation
or energy production in the form of NADH. This metabolism mimics the larger
scale carbon cycle, in that energy is stored as CH20 units and released by
burning those units to form CO2-
The methanotroph metabolic reactions are interesting from both a
chemical and economic standpoint. The first step in the process, the controlled
oxidation of methane to methanol by dioxygen, is particularly interesting due to
its kinetic difficulty. Current industrial processes to produce methanol from
101
methane require two steps (6). The first is the conversion of methane to
"synthesis gas" (CO + H2), which takes place over Ni, Al or Si catalysts, and the
second is conversion of the "synthesis gas" to methanol, which is done by using
Zn/Cu or Zn/Cr catalysts. Both reactions require pressures of 50-200 bar and
reaction temperatures of 250-900 *C. The MMO system performs this reaction at
25 *C and 1 atmosphere utilizing water as a solvent. It would clearly be cheaper
and safer to use catalysts that mimic the chemistry of MMO in industrial
methanol production processes. To further that goal, examination of the reaction
of methane and dioxygen in the MMO system is a first step in the design of new
catalysts.
The enzymes that catalyze the MMO reaction come in two forms, a
particulate MMO (pMMO) that contains copper and is membrane bound, and a
soluble MMO (sMMO) that contains iron and is found in the cytoplasm (7-10).
The sMMO enzymes are relatively simple to purify and are quite robust when
compared to the pMMO, and they have therefore been studied in more detail.
The stoichiometry of the MMO reaction is shown below in eq. 2.
MMO
CH 4 + NADH + H'+ 02 -- CH 30H + NAD+ + H 20 (2)
The sMMO hydroxylase protein (sMMOH) is the site of methane
activation. It is a heterodimer consisting of two copies each of three subunits,
MMOHcc (60646 Dal), MMOHs (45132 Dal) and MMOHy (19847 Dal), resulting
in a holoenzyme with a molecular weight of 251 kDal. It contains a non-heme,
carboxylate-bridged diiron center that is the site of methane oxidation. This
diiron unit is similar to centers found in a wide variety of enzymes, including
ribonucleotide reductase (RR) (11, 12), stearoyl acyl carrier protein A-9 desaturase
(13), phenol hydroxylase (14) and toluene-4-monooxygenase (15). The sMMO
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system also contains a reductase and a coupling protein. The structure of the
hydroxylase has recently been determined under a variety of conditions (16, 17),
and those data supplied important information about the mechanism of the
enzyme.
Three proposals relate the structure of the hydroxylase to its function.
Specifically, the MMOHa residues cysteine 151, threonine 213 and leucine 110
are hypothesized to have functions suggested by their positions in the crystal
structure. It was first postulated by Dalton and Nordlund that C151 in the M.
capsulatus (Bath) MMOH would occupy the same position in the active site as
tyrosine 122 from ribonucleotide reductase subunit R2, based on sequence
comparisons (18). The R2 iron center is responsible for converting Tyr122 to a
radical. Subsequently, it was proposed that a thiyl radical at C151 might be a part
of the mechanism of methane hydroxylation (19). The crystal structure confirmed
that C151 occupies a position similar to the RR R2 tyrosine residue, although the
sulfur atom of the cysteine is farther away from the iron center than the tyrosine
oxygen atom due to the difference in size between tyrosine and cysteine side
chains. A thiyl radical intermediate was recently observed by EPR spectroscopy
in a coenzyme B12-dependent RR that is responsible for abstraction of a
hydrogen atom from a ribose ring (20). A thiyl radical is possibly involved in the
mechanism of hydrocarbon hydroxylation.
Threonine 213 also has a corresponding residue in RR R2 subunit. It
occupies a position similar to that of serine 211 in the R2 protein, which is
responsible for shuttling protons from solvent into the active site (21). In the
structures of the reduced and oxidized frozen crystals, T213 is hydrogen bonded
to a solvent molecule and an acetate ion, respectively (17, 22). Both the water
molecule and acetate are further linked by hydrogen bonds to the diiron center
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via solvent ligands. The threonine residue is, therefore, part of an extensive
hydrogen bonding network that may function to feed protons into the active site.
Another possible interpretation of the roles of the Cys151 and Thr213
residues is based on the observation that they are among the few protonated
residues in the largely hydrophobic active site cavity. As such, they may serve to
communicate structural changes via hydrogen bonding in the hydroxylase
caused by binding of protein B or the reducatase to the diiron center, tuning its
activity to reflect the state of the protein.
The third residue mentioned above is leucine 110, which crystallographic
methods reveal to adopt two different orientations in different crystal forms (23).
This residue may act as a gate between two hydrophobic pockets, termed cavities
1 and 2, which are proposed to be involved in substrate access to the active site
iron center.
The ideal method to approach the testing of these proposals is site-
directed mutagenesis, combined with analysis methods previously established in
our laboratory, including X-ray crystallography and stopped-flow kinetics.
Interesting mutants at position 151 would include C151A and C151S. MMOH
C151S preserves the proton, but changes the electronic character of the residue.
The net effect would be that the hydrogen bonding role of C151 will very likely
be preserved, but that any radical that may be formed at that position in the
native enzyme may not be formed in the mutant C151S. The C151A mutant will
be useful as a control since neither hydrogen bonding nor radical formation is
possible. The mutants at T213 that would be most informative include T213A,
T213S, and T213C. Both T213S and T213C preserve the hydrogen bonding
capability, but remove a methyl group. The hydrogen bonding strengths of
serine and cysteine differ, and that difference may be observable kinetically if
T213 were responsible for delivering protons to the active site during turnover.
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The T213A mutant is, again, a control that removes the hydroxyl proton
completely. L110 mutants would include a number of smaller residues to observe
the effects of removing the proposed gate.
Generating these site-directed mutants depends on having the
hydroxylase expressed in a system that allows for easy changes in the
hydroxylase subunit gene sequence, and that allows the production of significant
amounts of protein for study. This topic is the subject of the present thesis
chapter.
A number of proteins homologous to the sMMOH have been expressed in
E. coli, including ruberythrin (24). It was produced in an insoluble, iron-deficient
form, which could be reconstituted by denaturing the protein with guanidinium
chloride, followed by dilution in the presence of Fe(II). The A-9 desaturase has
also been expressed in E. coli (25). High yields of soluble desaturase were
prepared through the use of an optimized lactose fed-batch fermentation
methodology, where lactose was used instead of IPTG as an inducer (26). The
toluene-4-monooxygenase (T4M) system is quite similar to the sMMO system
(15, 27). It has a hydroxylase with three subunits, a reductase and a protein B
homologue. It has been expressed in E. coli by inducing the expression systems at
very high cell densities, at low temperatures, at low IPTG concentrations and
with Fe(lI) media supplements. All three of these proteins were produced in an
insoluble form under standard expression conditions, requiring specialized
conditions for production of soluble material.
All of the proteins mentioned above, with the exception of T4M, are single
polypeptides. Expression of proteins with more than one subunit is often a
particular challenge, due to the need for subunit assembly in a foreign
environment. Few multisubunit proteins have been expressed in E. coli (28). The
most common strategy for expressing those kinds of systems is to prepare the
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individual subunits separately, and recombine them at a later stage to form the
holoprotein. Examples of this type of expression include recombinant actin and
myosin subunits (29, 30), the two subunits of the human class I
histocompatability antigen (HLA)-A2 (31), RNA polymerase I initiation factor
SL1 (32), and two subunits from the corrinoid/iron-sulfur protein from C.
thermoaceticum (33). A second strategy for expression is to produce an "operon"
on a plasmid, either by replication of the wild-type operon or by construction of
an artificial operon. The T4M system described above was expressed by using
the latter methodology.
Several groups have reported progress in expressing the sMMO genes.
The M. capsulatus (Bath) sMMOB and sMMOR proteins have been expressed in
E. coli (34-36). sMMOH~ mutants have also been generated in M. trichosporium, an
important step for producing homologous mutants (37). Heterologous
expression of the M. trichosporium sMMO system in P. putida F1 has been
accomplished by using the pMMB broad host range (38), but no subsequent
purification of the protein products was reported.
Expression of heterologous proteins in E. coli often results in the formation
of protein aggregates, termed inclusion bodies (28, 39-42). These inclusion bodies
contain the protein of interest in a non-native and non-active form.
Inclusion bodies are the result of the absence of some condition required
for protein folding in a heterologous system. This problem has been most evident
for eukaryotic proteins that have post-translational modification requirements, in
proteins that have more than one subunit, in proteins that may require specific
chaperonins for correct folding, and in proteins requiring the assistance of other
proteins for insertion of a cofactor (43).
There are two broad methods for solving the problem of inclusion bodies,
in vivo and in vitro. In vivo methods prevent the formation of inclusions by
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changing the conditions inside the cell during protein induction (28). Examples
include growing cultures at a lower temperature, using lower IPTG
concentrations, using higher media salt concentrations (to increase the
hydrostatic pressure inside the cell), and changing expression systems or
organisms. In vivo methods often fail, since there is very little that one can do to
change the physical environment inside the cell. In vitro solutions involve
collecting the inclusions and subjecting them to a procedure to refold the protein
(42, 44). There are two common examples of such procedures. One can solubilize
the inclusion bodies by using a denaturant such as urea or guanidinium
hydrochloride and then refold them by dialysis to remove the denaturant.
Alternatively one can solubilize the inclusions by using a detergent such as
sarcosyl, and then renature the protein by detergent removal. In vitro methods
are the most common solutions reported in the literature, and if they work well,
the formation of inclusion bodies can be an advantage since they are easily
isolated in high purity from soluble protein impurities.
This chapter reports on progress toward the expression of the soluble
MMOH in E. coli. Construction of a series of vectors for both "operon" and
individual subunit expression is described, together with the use of those
systems to produce substantial amounts of the three sMMOH subunits as
inclusion bodies. Both refolding and expression conditions were systematically
changed in attempts to produce active sMMOH. Finally, based on observations
and deductions from on the data reported, a future course of action to express
the hydroxylase is outlined.
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Materials and Methods
All chemicals were from Sigma-Aldrich, except IPTG (Boeringer-
Mannheim) and when noted otherwise. All enzymes were from New England
Biolabs unless stated explicitly. Manufacturer's instructions were followed
exactly in their use unless stated. All restriction digests were carried out at 37 *C
over 6 h. Double digests were performed first with low-salt optimal enzyme (3 h)
followed by addition of high-salt buffer and the second enzyme (3 h). Ligations
were carried out overnight at 14 'C. E. coli strains INVaF' or XL1-Blue were used
for all DNA manipulations. E. coli strain JM105 was used as expression host at 37
*C unless mentioned otherwise.
Low Pressure Chromatography sMMOH Pur'fication Procedure. The sMMOH
and a crude mixture of sMMOB and sMMOR (termed B/C mix) were prepared
as described previously (45, 46). Average iron content of the hydroxylase was
3.4-3.6 Fe/protein and the average activity (in units as described in the literature)
was 220-250 mU/mg. An SDS-PAGE gel showing the quality of the protein
obtained in this manner is presented in Figure 2-3.
Production of MMOH Polyclonal Antibodies. Two female New Zealand
white rabbits were obtained. Blood samples (15 mL) were taken from each
animal before any injections were made. The blood was incubated at room
temperature for 4 h to clot, then left at 4 *C for 12 h to retract the clot. The serum
was decanted and spun in a table-top centrifuge for 10 min at 200 rpm to remove
additional blood particulates. The serum was frozen in liquid nitrogen and
stored at -20 *C.
Protein antigen injections were prepared by first exchanging and
concentrating a native sMMOH sample into PBS at a concentration of 3 mg/mL.
A 2 mL sample of the exchanged protein solution was mixed with 2 mL of
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Freund's Complete Adjuvant for the first injection or 2 mL of Freund's
Incomplete Adjuvant for all subsequent injections. This solution was either
vortexed vigorously at 4 *C for 30-60 min or exchanged rapidly between two
syringes connected by a narrow stopcock until a thick emulsion formed. This
emulsion was divided into two 2 mL syringes and given to MIT Animal Care
personnel to inject each rabbit at multiple subcutaneous sites. Two to three
weeks after each injection, the animals were bled (15 mL), and serum containing
antibodies to the hydroxylase was isolated as described above.
This cycle was repeated 6 times. The final bleed was done by fatal cardiac
puncture in which most of the blood from the rabbit was collected, resulting in
approximately 50 mL of material. Total serum collected was approximately 120
mL. The serum was used in subsequent experiments without further
purification. Protein concentration was approximately 25 mg/mL in the sera
samples.
ELISA Assays. A standard sMMOH solution of known purity and quality
was used as the standard for all ELISA assays. ELISA 96-well polystyrene plates
were purchased from Coming.
In each ELISA assay, one column was reserved as a blank, no-protein
control, and another was reserved for a sMMOH standard. Each row was a 1:3
dilution of the row above it, resulting in a typical range of concentrations in the
sMMOH column from 160 pg/mL to 73 ng/mL. All dilutions were done in PBSN
buffer (140 mM NaCl, 10 mM KCl, 25 mM NaPO4 at pH 7.4). The protein solution
to be tested was diluted and treated in an identical manner to the sMMOH
standard.
Protein aliquots of 50 pL were placed in each well. The plate was wrapped
in plastic and either baked at 37 *C for 2 h or left to incubate at 25 'C overnight.
The protein solution was washed out of the wells with 3 rinses of deionized
109
water. The remaining sites for protein binding in the wells were blocked by
filling each well to the brim with approximately 500 gL ELISA blocking buffer
(170 mM H 3B 0 4 at pH 8.5, 120 mM NaCl, 0.5% Tween 20, 1 mM EDTA, 0.25%
BSA, 0.05% NaN3) and soaking for 30 min. The blocking buffer was removed by
using 3 rinses of deionized water. A solution of 625 ng/mL antiserum was made
by dilution of the anti-sMMOH stocks described above in blocking buffer.
Aliquots of 50 gL anti-sMMOH antibody were added to each well and allowed to
soak at room temperature for 2 h. The antibody was washed out by rinsing 3
times with deionized water, soaking in blocking buffer for 10 min, and rinsing
again 3 times in deionized water. A solution of 500 ng/mL Protein A-alkaline
phosphatase conjugate was made by dilution of a stock solution in blocking
buffer. Aliquots of 50 pL volume of the conjugate were added to each well and
allowed to soak in for 2 h. The conjugate was washed out by rinsing 3 times with
deionized water, soaking in blocking buffer for 10 min, and rinsing again 3 times
in deionized water. A solution of 1.0 mg/mL p-nitrophenol phosphate (pNPP)
was prepared by dissolving a pre-weighed tablet in an appropriate volume of
200 mM Tris buffer at pH 8.0. Aliquots of 200 gL volume of the pNPP solution
were added to each well. The color of the pNP product of the alkaline
phosphatase reaction was allowed to develop over 2 to 16 h, depending on the
strength of the color.
The plates were read on an EFLab Titertek Multiskan model 110V
multiwell plate reader utilizing a lamp filter set to 405 nm. The absorbance
values for the sMMOH standard were used to construct a standard curve, and
the protein concentration of sMMOH in the unknown samples was determined
from that curve.
Western Blots. An SDS-PAGE gel containing one lane of sMMOH pure
standard and other lanes with unknown samples were prepared and blotted onto
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nitrocellulose. After blotting, the nitrocellulose membrane was sealed in a
chamber containing 100 mL TTBS (0.1% Tween 20, 100 mM Tris pH 7.5, 0.9%
NaCl) and allowed to soak for 1 h. The TTBS was removed and replaced with 40
mL of a 12.5 g/mL solution of anti-sMMOH serum, which was prepared by
dilution of the stock antisera described above in TTBS. After a 1 h soak, the
membrane was removed and washed four times with 50 mL TTBS. A stock
solution of goat anti-rabbit IgG(H+L)-horseradish peroxidase (HRPO) conjugate
(obtained from Biorad) was diluted 1:3000 in 20 mL of TTBS. The membrane was
soaked in that solution for 1 h, and washed four times with 50 mL TTBS. A 20 mL
solution of 0.015% H202, 3 mM 4-chloro-1-naphthol, 0.9% NaCl and 100 mM
Tris pH 7.5 was prepared and the membrane was soaked in that solution until
adequate color development was observed. The HRPO reaction was stopped by
a water wash, and the membrane was allowed to dry in air. A sample western
blot prepared by using that protocol is shown in Figure 2-4.
Genomic DNA Sample Preparation. All procedures were carried out at 25 *C
unless noted. M. capsulatus (Bath) cell paste (1 gram) was thawed and
resuspended in 9.8 mL of TE (pH 8). SDS (200 gL of a 25% solution) and 1.5 mg
proteinase K were added and mixed gently, followed by incubation at 37 *C for 2
h and 60 *C for 20 min. SDS (600 gL of a 25% solution) was added and incubated
at 60 *C for 10 min. Sodium perchlorate (2.5 mL of a 5 M solution) was added,
mixed gently, then the solution was again incubated at 60 *C for 15 min. The
resulting solution was extracted with an equal volume of 25:24:1
phenol:chloroform:isoamyl alcohol by shaking gently for 30 min and centrifuged
at 20,000 g for 20 min. The viscous aqueous layer containing the genomic DNA
was removed by using a wide end pipet tip. This extraction procedure was
repeated until no white precipitate formed at the phase boundary (typically 2-3
times). The DNA/RNA solution was precipitated by slow addition of 95%
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ethanol at -80 'C to form two layers. The layers were mixed slowly by gentle
agitation with a thin glass rod, curved at the tip. The DNA/RNA pellet
accumulated on the glass, and was subsequently dried and resuspended in 7 mL
of 150 mM NaCl/150 mM sodium citrate (pH 7). DNase-free RNase was added
to the solution to 50 mg/mL, and the mixture was incubated at 37 *C for 30 min.
The solution was phenol extracted and precipitated as above, except that the
DNA pellet was washed in 70% ethanol before speed-vac drying. The pellet was
resuspended in 5 mL TE (pH 7.4).
Purification of PCR Primers for pDEC002. The following primers (5' to 3')
were ordered from MIT Biopolymers and stored as deprotected, lyophilized
powders at -20 'C: XN1.1: GGCCATGGAGGAGGTAAGTAATGGCACTTAG-
CACCGCA, XC1.1: CTCGAATTCTCAATTGAATGCCTTCACCG-GGTT, YN1.1:
GGGAATTCAGGAGGTTCGATATGAGCATGTTAGGACAA, YC1.1: CTCAC-
GCGTTCAATCCTGCCAGAACCGCTTTAA, ZN1.1: GGACGCGTAGGAGGTA-
TGACATGGCGAAACTGGGTATA, ZC1.1: CTCGAGCTCTCAGTGCGGGCA-
CTGCAGATGCAC. Each primer sample was resuspended in 100 gL of water, a
40 gl aliquot of which was mixed with 10 gL of USB Sequenase stop solution.
These six samples were loaded onto 7 M urea 12% polyacrylamide gels, which
were run for 1.75 h at 250 mV at 50 *C. The bands corresponding to the desired
primers were visualized by using UV shadowing and were excised from the gel
by using fresh, clean razor blades. The gel slices were crushed and the DNA was
eluted by soaking overnight at 37 *C in 1 mL of 3 M sodium acetate. The samples
were extracted by addition of an equal amount of 25:24:1 phenol:chloroform:
isoamyl alcohol, vortexing for 15 s, spinning down in a microcentrifuge for 30 s,
and pipetting off the top aqueous layer. The water layer was added to 2.5X
volumes of 95% ethanol, vortexed and kept at -80 *C for 30 min. The tubes were
spun at 4,000 rpm for 30 min to pellet the primers. The supernatant was decanted
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and the pellets were washed in 1 mL of 70% ethanol. The samples were spun
down at 4,000 K for 30 min and the supernatant was decanted. The pellet was
dried under vacuum and resuspended in 40 gL TE (pH 7.4).
PCR Conditions for pDECOO2. The following were added to a total volume
of 100 gL for each of the three subunits: 1000 ng of genomic DNA, 100 pmol of
the N-terminal primer (_N1.1), 100 pmol of the C-terminal primer (-C1.1), 1 gL of
20 mM dNTPs, 10 gL of 1oX Taq polymerase reaction buffer and 1 gL Taq
polymerase (5 units). These samples were placed in a thermocycler that was
programmed to with the following cycle: 1 x (7 min at 94 *C, 2 min at 60 *C, 2
min at 72 *C), 38 x (2 min at 94 *C, 2 min at 60 *C, 2 min at 72 *C), 1 x (2 min at 94
*C, 2 min at 60 *C, 10 min at 72 *C). Each of the three samples was purified from
reaction buffer salts, primers and dNTPs by using the Qiagen PCR spin
quantitation kit. An agarose gel showing the results of the PCR reactions is given
in Figure 2-5.
Construction of pDEC002. Direct 4-piece ligations of mmoX, mmoY, mmoZ
and the chosen expression vector pTrc99A did not perform adequately, so a more
complex serial cloning procedure was adopted, as diagrammed in Figure 2-6. A
double digest of 1 gg of pSL301 (Novagen) and 1 gg of X1.1 PCR product was
performed by using EcoR I and Nco I. The cut pSL301 was treated with CIP
(Boeringer-Mannheim) and both restriction digests were purified by agarose gel
electrophoresis followed by treatment with the USBioClean kit. A ligation was
performed with 2 gL Boeringer-Mannheim T4 ligase, 2 gL 1oX T4 ligation buffer,
2 pL 10 mM ATP, 0.1 gg digested, phosphatased pSL301, and 0.1 Rg digested
X1.1 in a total volume of 20 pL. The reaction was carried out at 4 *C overnight.
The entire ligation reaction was transformed into E. coli strain JM105 made
competent by using the RbCl Hanahan protocol (47). The transformed cells were
plated onto LB plates (75 pg/mL ampicillin). Colonies were screened by
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restriction mapping with EcoR I and Nco I. The positives were labeled pSL301-
mmoX. Approximately 1 jg of pSL301-mmoX and 1 gg of Y1.1 PCR product were
double digested with EcoR I and Mlu I. The cut pSL301-mmoX was treated with
CIP and both digests were purified by agarose gel electrophoresis followed by
treatment with the USBioClean kit. A ligation was done with 2 gL Boeringer-
Mannheim ligase, 2 gL 1oX ligation buffer, 2 gL 10 mM ATP, 0.1 jg digested,
phosphatased pSL301-mmoX, and 0.1 jg digested Y1.1 in a total volume of 20 jL.
The reaction was carried out at 4 *C overnight. The entire ligation reaction was
transformed into competent E. coli strain JM105. The transformed cells were
plated onto LB plates (75 gg/mL ampicillin). Colonies were screened by
restriction mapping with EcoR I and Mlu I. The positives were labeled pSL301-
mmoXY*. Approximately 1 jg of pSL301-mmoXY* and 1 jg of Z1.1 PCR product
were double digested with Mlu I and Sac I. The cut pSL301-mmoXY* was treated
with CIP, and both restriction digests were purified by agarose gel
electrophoresis followed by treatment with the USBioClean kit. A ligation was
carried out with 2 jL ligase, 2 jL 1oX ligation buffer, 2 jL 10 mM ATP, 0.1 jg
digested, phosphatased pSL301-mmoXY*, 0.1 jg digested Z1.1 in a total volume
of 20 jL. The reaction was performed at 4 *C overnight. The entire ligation
reaction was transformed into competent E. coli strain JM105. The transformed
cells were plated onto LB plates (75 jg/mL ampicillin). Colonies were screened
by restriction mapping with Mlu I and Sac I. The positives were labeled pSL301-
mmoXY*Z.
A mistake in the published sequence of the mmoY gene was discovered
midway through the cloning procedure described above (see chapter one for a
description of the error). The C-terminal cloning primer for the mmoY gene was,
therefore, designed erroneously, and the sequence of the pDECO02 gene was not
as expected. A new PCR primer, YC20 (5'-TAGTTACGCGTTTATTTCAGTC-
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CTGCCAGAAC-3') was designed to correct the error. YC20 was synthesized on a
Cruachem DNA synthesizer and PAGE-purified according to manufacturer's
instructions. A PCR reaction was carried out by adding 20 pmol of primer YC20,
20 pmol primer YC11, 0.1 gg of pCH4, 2 gL of 10 gM dNTPs, 10 pL 1oX Taq
polymerase reaction buffer and 1 jL of Gibco BRL Taq polymerase (licensed for
PCR by Hoffman-La Roche) in a total volume of 100 jL. The samples were
overlaid with 75 jL mineral oil and placed in a thermocycler set to run the
following cycle: 1X (5 min at 94 'C), 30 X (1 min at 94 *C, 1 min at 60 *C, 1 min at
72 *C), 1 X (8 min at 72 C). The PCR reactions were cloned into the pCRII vector
(purchased from Invitrogen) directly by adding 1 jL of the PCR reaction without
purification to a 10 gL ligation reaction containing 1 jL pCRII vector, 1 jL ligase
(from Boeringer-Mannheim) and 1jL ligase buffer. The ligation reactions were
transformed into INVxF' cells and selection of positive mmoY insert clones was
done by using a combination of cx-complementation and restriction mapping.
The mmoY insert of interest was isolated by cutting selected pCRII-mmoY clones
with Mlu I and EcoR I. A sample of plasmid pSL301-mmoXY*Z was also cut by
Mlu I and EcoR I to excise the incorrect mmoY insert. The appropriate DNA
fragment from each restriction digest was purified by use of Millipore MP filter
units for purification of DNA from agarose gel slices. The mmoY correction insert
and the pSL301-mmoXY*Z plasmid shell were ligated together to form pSL301-
mmoXYZ. The corrected sMMOH artificial operon was cut with Nco I and Hind
III to excise the operon fragment, which was subsequently ligated into the
multiple cloning site of pTrc99A to form pDEC002. The structure of this plasmid
was verified by restriction mapping and is shown in Figure 2-7.
Sequencing of pDECOO2. The entirety of the pDECO02 plasmid was
sequenced by using the protocols and primers described in chapter one. The
mmoX, mmoY and mmoZ genes were all sequenced completely on both sense and
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antisense strands, along with approximately 100 bp on either side of the cloned
genes.
Expression of MMOH by using the pDECO02 system. The pDECO02 plasmid
was transfected into JM105. The standard MMOH expression experiment was as
follows. A 5 mL culture grown in LB media supplemented with 100 Rg/mL of
ampicillin was grown to saturation overnight. A 100 gL sample of this culture
was diluted into 100 mL of LB media containing 100 gg/mL ampicillin. The
culture was allowed to grow until the cells reached on O.D. of 0.6 to 0.8. IPTG
was added to a final concentration of 0.4 mM and the cells were allowed to grow
for another 2 h. The culture was centrifuged at 4,000 rpm in a Sorvall centrifuge
for 10 min, and the media was discarded. The cells were resuspended in 20 mL of
cracking buffer (25 mM MOPS at pH 7,5 mM MgCl 2, 5 mM sodium
thioglycolate, 1 mM 6-aminocaproic acid, 1 mM 3,5-diaminobenzoic acid, and
approximately 1 mg/mL DNase), and passed through a French Pressure Cell
(SLM-Aminco) at 15,000 psi twice. The crude cell lysate was ultracentrifuged at
40,000 rpm in a Beckman ultracentrifuge for 90 min. The supernatant was saved
as the soluble fraction, and the pellet was solublized in cracking buffer with the
addition of 6 M urea. An SDS-PAGE gel showing the results of a sample
pDECO02 expression experiment is shown in Figure 2-8.
A4MOH Inclusion Purification. A 10 mL sample of pDECO02 system
inclusions (approximately 1 mg/ml) solubilized in standard cracking buffer plus
6 M urea was loaded on a 30 mL DEAE Biogel (Pharmacia) column equilibrated
in 25 mM MOPS (pH 7)/6 M urea. The column was washed with 32 mL of buffer
at 1 mL/min, and was washed in a NaCl gradient from 0 to 300 mM over 192
min at 1 mL/min. The column was washed with 300 mM NaCl buffer for 76 min
(at 1 mL/min).
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Post-Expression Refolding Experiments
Dialysis Reconstitution of Native MMO Hydroxylase Isolated from M.
capsulatus (Bath). A 10 mL sample of active hydroxylase (1 mg/mL) was
prepared. Powdered urea was added slowly with slow stirring to bring the
sample to 6M. Stirring continued for 1 h to insure complete denaturation of
protein. This sample was placed in a dialysis bag and dialyzed against 1 L of
cracking buffer plus 0.5 mM ferrous ammonium sulfate for 8 h. The buffer was
exchanged and dialysis was continued for another 8 h. During this time, a
flocculent precipitate formed in the bag. After dialysis was complete, the
contents of the bag were ultracentrifuged at 40,000 rpm for 90 min. The
supernatant was drop frozen at -80 'C and the pellet was solublized in 5 mL of
cracking buffer plus 6M urea. Similar experiments were performed by using 4 M
guanidinium hydrochloride in place of the 6 M urea, with identical results.
Dialysis Reconstitution of Insoluble Expressed Hydroxylase Isolated from E. coli.
A 3 mL sample of the insoluble sMMOH pellet described above was diluted in 27
mL of cracking buffer plus 4 M guanidine hydrochloride (approximately 1
mg/mL). A 10 mL sample of the diluted protein was placed in each of three
dialysis bags (10 kDa MW cutoff). These three bags were each placed in 1 liter of
cracking buffer, 1 liter of cracking buffer plus 0.5 mM ferric EDTA, and 1 liter of
cracking buffer plus 0.5 mM ferrous ammonium sulfate respectively. Stirring
continued for 8 h, after which time the outer buffer was exchanged, and stirring
was continued for another 8 h. During this dialysis, a white flocculent precipitate
formed in the bags, usually after 1 or 2 h. After dialysis was complete, the
contents of the bags were ultracentrifuged at 40,000 rpm for 90 min. The
supernatant was drop frozen at -80 *C and the pellet was solublized in cracking
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buffer plus 4M guanidine hydrochloride. The supernatant from each of the three
dialyses was analyzed on SDS-PAGE gels, shown in Figure 2-9.
Anaerobic Fe(II) Dialysis Reconstitution of Insoluble Expressed Hydroxylase
Isolatedfrom E. coli. In analogy with the Desulfovibrio vulgaris rubrerythrin
refolding procedure (24), an anaerobic denaturant dialysis was attempted to
refold the MMOH inclusions. A 5 mL volume of a 50 gM MMOH solution in 6 M
urea/cracking buffer solution was thawed in a 500 mL RB flask with a 70 gL
aliquot of P-mercaptoethanol. The flask was sealed with a septum and degassed
by 20 cycles of evacuation followed by back filling with argon gas. This protein
sample along with 250 mL of degassed 25 mM MOPS (pH 7) buffer and a vial of
0.1 g Fe(II)(NH) 2(SO 4)2 and 0.01 g ascorbic acid were cycled into an anaerobic
box, where the iron/ascorbate powders were added to the 250 mL of buffer. The
buffer was added slowly to the protein solution over two h, diluting the urea to
120 mM. The protein solution was ultracentrifuged to remove the precipitated
protein and concentrated to a volume of 10 mL in an Amicon concentrator.
This anaerobic Fe(II) refolding experiment was also carried out by using
denatured MMO hydroxylase as isolated from M. capsulatus (Bath). All
conditions were identical, except that the starting concentration of MMOH in the
5 mL sample was 5 gM.
Sarcosyl Lysis Growth. The standard growth protocol was followed up to
the resuspension step. The cells were resuspended in 10 mL of cracking buffer. A
200 gL aliquot of 10% w/v N-lauroyl sarcosine (sarcosyl detergent) was added,
and the sample was passed through the French press (2 passes, 1000-1200 psi). A
1 mL sample of 20% 1-O-octyl-p-D-glucopyranoside (octylglucoside detergent)
was added and the mixture was stirred for 20 min to allow the sarcosyl to diffuse
into the octylglucoside micelles. The sample was ultracentrifuged at 40,000 rpm
for 90 min. The supernatant was drop frozen at -80 *C and the pellet was
118
solublized in cracking buffer plus 6 M urea. Both the supernatant and pellet were
examined by SDS-PAGE gels, shown in Figure 2-10. All of the hydroxylase
remained in the insoluble form.
Detergent Lysis Screening. Four buffer solutions containing various
detergents were made according to the following procedure. All buffers
contained 25 mM MOPS (pH 7), 1 mM aprotinin, 1 mM pepstatin, 1 mM PMSF
and 5 mM sodium thioglycolate. Buffer NI contained 0.5 mM Nonidet P40. Buffer
TW contained 0.1 mM Tween 20. Buffer DM contained 1.6 mM
dodecylmaltoside. Buffer OG contained 25 mM octylglucoside.
For each of these buffers, the standard MMOH inclusion preparation was
followed, excepting that the cracking buffer was replaced by detergent buffer. An
SDS-PAGE gel of those samples is shown in Figure 2-11.
Sarcosyl Pellet Solubilization. The standard growth protocol for the
pDECO02/JM195 system was followed to the ultracentrifugation step. After
ultracentrifugation, the supernatant was drop frozen, and the pellet was
resuspended in 3 mL of SPS buffer (25 mM MOPS at pH 6.95, 5 mM sodium
thioglycolate {added immediately before use}, 1 mM PMSF, 20 Rg/mL aprotinin,
5 pg/mL leupeptin, 2.5 gg/mL pepstatin, 1.5% sarcosyl detergent). This
suspension was homogenized in a glass homogenizer. The sample was
ultracentrifuged at 40,000 rpm for 20 min and the supernatant was mixed gently
into 24 mL OG buffer (25 mM MOPS at pH 6.95, 5 mM sodium thioglycolate
{added immediately before use}, 1 mM PMSF, 20 gg/mL aprotinin, 5 pg/mL
leupeptin, 2.5 gg/mL pepstatin, 2.5% octylglucoside detergent, 1 M NaCl). This
sample was ultracentrifuged for 30 min at 40,000 rpm. The supernatant was drop
frozen at -80 'C and the pellet was solublized in 5 mL cracking buffer plus 6 M
urea. The first and second supernatants and the pellet were analyzed by SDS-
PAGE as shown in Figure 2-12. A 10 mL sample of the second supernatant was
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placed in a 10 mL dialysis bag and dialyzed against 1 liter cracking buffer for 8 h
to remove the octylglucoside/sarcosyl micelles. During this initial period, no
protein precipitated. The outer buffer was exchanged and dialysis continued for
8 h. During this period, a white precipitate formed in the bag. After dialysis, the
sample was ultracentrifuged for 30 min at 40,000 rpm. The supernatant was
concentrated to 2 mL by using Centricon-10 concentrators, and the pellet was
solubilized in 2 mL cracking buffer plus 6 M urea.
Alteration of Expression Conditions
Low Temperature Induction Growths. The standard growth protocol was
followed, except that the 2 h induction period after addition of IPTG was carried
out at 30 *C and 25 *C for two separate 500 mL growths. An additional trial was
done under standard conditions, excepting that the IPTG was added at O.D. 0.2.
Results as monitored by SDS-PAGE gels were identical to the 37 *C induction
growths.
E. coli Strain Screening. The pDECO02 vector was transfected into the
following E. coli strains: BL21(DE3), HMS174, HMS174(DE3), C600, HB101, K12,
XL1-Blue, and JM105 (as a control). These strains were grown by following the
pDECO02 protocol. All strains performed identically to JM105.
Variation of Media Content. Variants on the protein expression procedure
were attempted to induce production of soluble protein. The medium was
changed to M-9 minimal media, and to TYPGN (super-rich). Results were
identical to those obtained under standard conditions.
Expression System Screening (pDECO1O). The fragment of pDECO02
containing the artificial operon (mmoXYZ) was excised from the plasmid by
using Nco I and HinD III and ligated into the pET11d vector to form pDECO10.
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This plasmid was transfected into the BL21(DE3) strain and grown by using the
pDECO02 protocol. An SDS-PAGE gel showing the results of that system is
shown in Figure 2-13.
Individual Subunit Expression
Construction of pDEC05x. Linker oligonucleotides linkX1 (5'-AATTTGC-
GGATCCGCTCGA-3'), linkX2 (5'-AGCTTCGAGCGGATCCGCA-3'), linkYl (5'-
CATGGAATGAGGATCCGCGT-3') and linkY2 (5'-AATTACGCGGGATCC-
TCATTC-3') were synthesized on a Cruachem DNA synthesizer and were
purified by PAGE according to Cruachem directions.
Plasmid pDECO02 was cut with BamH I and EcoR I and was purified from
an agarose gel slice by using a Millipore MP filter unit. Approximately 0.1 pg of
the pDECO02 fragment was ligated with 100 pmol of each linker oligonucleotide
linkX1 and linkX2. The resulting plasmid, with the EcoR I site removed and a
BamH I site added via linker design, was restriction mapped and labeled
pDECO50.
Plasmid pDECO02 was cut with Nco I and EcoR I and was purified from
an agarose gel slice by using a Millipore MP filter unit. Approximately 0.1 jg of
the pDECO02 fragment was ligated with 100 pmol of each linker oligonucleotide
linkY1 and linkY2. The resulting plasmid, with the EcoR I site removed and a
BamH I site added via linker design, was restriction mapped and labeled
pDEC055. The construction and structure of plasmids pDEC050 and pDEC055
are shown in Figures 2-14 and 2-15, respectively.
Construction of pDEC060. This construction is diagrammed in Figure 2-16.
Plasmids pDEC050 and pET20b were digested with Nco I and HinD III. The
agarose gel bands corresponding to the mmoX cassette and the pET20b fragment
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were purified by using Millipore MP filter units. Approximately 0.1 Rg of each
DNA fragment were ligated together. The resulting pDEC060 plasmid was
restriction mapped to confirm its structure as shown in Figure 2-17.
Construction of pDEC070. Primer oligonucleotides XN30 (5'-
GCGCCATGGCACTTAGCACCGCAACC-3') and XC30 (5'-CTCAAGCTTTCA-
ATTGAATGCCTTCACCGG-3') were synthesized on a Cruachem DNA
synthesizer and purified by PAGE according to manufacturer's specifications.
The PCR reactions were carried out by adding 2.60 gg pCH4 template DNA, 20
pmol of each primer, 2 gL of 10 gM dNTPs, 10 pL 1oX Taq polymerase reaction
buffer and 1 gL of Gibco BRL Taq polymerase in a total volume of 100 pL. They
were placed in a thermocycler set to cycle for 1X (2 min at 94 *C), 10 X (2 min at
94 'C, 2 min at 60 *C, 6 min at 72 *C), 1 X (10 min at 72 *C). The reaction products
were cloned into the pCRII vector (purchased from Invitrogen) directly by
adding 1 pL of the PCR reaction directly to a 20 gL ligation reaction containing 1
gL pCRII vector, 1 gL ligase (from Boeringer-Mannheim) and 2 gL ligase buffer.
The ligation reactions were transformed into INVxF' cells. Selection of insert
clones was done by using a-complementation followed by EcoR I digests to
identify inserts of the correct size.
The mmoX insert was excised by using Nco I and HinD III and ligated into
the multiple cloning site of pET32a. The plasmid was labeled pDEC070 and
restriction mapped. Its construction is shown in Figure 2-16, and its structure is
shown in Figure 2-17.
Simple MMOH subunit expression - pDEC05x. Both pDECO50 and pDEC055
were transformed into JM105. A 5 mL culture of each strain was grown in LB
amp media (100 gg/mL ampicillin) to saturation overnight. A 1 mL sample of
this culture was diluted into 1000 mL of LB amp media. The culture was allowed
to grow until the cells reached on O.D. of 0.6. IPTG was added to a final
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concentration of 0.4 mM and the cells were allowed to grow for another 2 h. The
culture was centrifuged at 4,000 rpm in a Sorvall centrifuge for 10 min, and the
LB supernatant was discarded. The cells were resuspended in 40 mL of cracking
buffer (25 mM MOPS at pH 7,5 mM MgCl 2, 5 mM sodium thioglycolate, 1 mM 6-
aminocaproic acid, 1 mM 3,5-diaminobenzoic acid, and approximately 1 mg/mL
DNase), and passed through a French Pressure Cell (SLM-Aminco) at 15,000 psi
twice. The crude cell lysate was ultracentrifuged at 40,000 rpm in a Beckman
ultracentrifuge for 90 min. The supernatant was saved as the soluble fraction,
and the pellet was solublized in cracking buffer with the addition of 6 M urea.
The results of this expression are shown in Figure 2-18.
Periplasmic Expression of sMMOHa - pDEC060. The pDEC060 plasmid was
transformed into BL21(DE3) cells. A cell culture procedure identical to the one
described above was carried out by using that strain. Results are shown in Figure
2-19.
Thioredoxin-sA4MOHa subunit expression. A 10 mL culture of an
AD494(DE3)/pDECO70 strain containing the sMMOHx-thioredoxin fusion gene
was grown in LB amp media (100 gg/mL ampicillin) to saturation overnight. A 6
mL culture sample was diluted into 6 L of LB amp media. The culture was cooled
to 20 'C after the cells reached on O.D. of 0.6. IPTG (Boeringer-Mannheim) was
added to a final concentration of 0.4 mM and the cells were allowed to grow for
another 2 h at 20 *C. The culture was centrifuged at 4,000 rpm in a Sorvall
centrifuge for 10 min, and the LB supernatant was discarded. The cells were
resuspended in 40 mL of cracking buffer (25 mM MOPS at pH 7,5 mM MgCl 2, 5
mM sodium thioglycolate, 1 mM Pefabloc SC, and approximately 1 mg/mL
DNase), and passed through a French Pressure Cell (SLM-Aminco) at 15,000 psi
twice. The crude cell lysate was ultracentrifuged at 40,000 rpm in a Beckman
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Ultracentrifuge for 90 min. The supernatant contained the soluble portion of the
sMMOH alpha-thioredoxin fusion, and was saved for purification.
Purification of sMA4MOHa. The soluble cell lysate was applied to a 25 mL
2+Ni -NTA resin column at 1 mL/min. Following loading, the column was
washed with buffer containing 20 mM Tris at pH 7.9, 500 mM NaCl and 5 mM
imidazole at 1 mL/min. The bound proteins were eluted by using a gradient of 5
mM imidazole to 150 mM imidazole over 1 h at 1 mL/min, followed by washing
of the column with 150 mM imidazole over 1 h at 1 mL/min. The alpha-
thioredoxin fusion elutes at approximately 100 mM in a very broad peak.
The crude alpha-thioredoxin fraction was exchanged into buffer
containing 20 mM Tris pH 7.9,150 mM NaCl and 2.5 mM CaCl 2 and
concentrated to a volume of approximately 10 mL. 3 units of thrombin
(Novagen) were added to the crude mixture, and the cleavage reaction was
allowed to proceed for 16 h at 4 *C.
The crude protein solution was applied to a 25 mL Ni 2-NTA resin column
at 1 mL/min. The flow-through fractions containing pure alpha subunit were
collected.
Protein samples were analyzed by using SDS-PAGE gels and Western
blotting. Protein concentrations were determined by using ELISAs. Iron
concentration was determined by using the ferrozine assay. Results are shown in
Figure 2-21.
EPR Mixed-Valent Sample Preparation. Protein samples, either native
hydroxylase or expressed sMMOHa, of approximate concentration 50 gM and
approximate volume of 250 gL were prepared by concentration in Centriprep 10
concentrator units. Stoichiometric amounts of the mediators potassium indigo
tetrasulfonate, methylene blue and phenazine methosulfate were added to the
sample. The sample was degassed by 15 cycles of vacuum evacuation followed
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by argon backfilling. A degassed solution of 5 mM sodium dithionite in 50 mM
MOPS (pH 8.6) buffer was made and used to titrate the protein solution until the
methylene blue changed from blue to yellow. The sample was anaerobically
transferred to a quartz EPR tube and frozen in liquid nitrogen. Results are shown
in Figure 2-22.
EPR Reduced Sample Preparation. Expressed sMMOHoa samples of
approximate concentration 100 pM and approximate volume of 250 gL were
prepared by concentration in Centriprep 10 concentrator units. A stoichiometric
amount of the mediator methyl viologen was added to the sample. The sample
was degassed by 15 cycles of vacuum evacuation followed by argon backfilling.
A degassed solution of 5 mM sodium dithionite in 50 mM MOPS (pH 8.6) buffer
was made and used to titrate the protein solution until the methyl viologen
changed from yellow to blue. The sample was anaerobically transferred to a
quartz EPR tube and frozen in liquid nitrogen.
Results
The template for most of the PCR cloning discussed above was the pCH4
plasmid, a gift from Prof. J. Colin Murrell. This plasmid is a cDNA copy of the
entire sMMO operon cloned into pBR325 (48). The sequence and structure of this
operon can be found in chapter one. The initial pDECO02 plasmid cassettes
(mmoX, mmoY* and mmoZ) were amplified from a genomic DNA sample directly
prepared from M. capsulatus (Bath) cell paste.
The plasmids in this chapter were designed by using the commonly used
expression-cassette strategy (49). This methodology allows for very precise
control over the design of the expression plasmid. By designing PCR primers
with mismatches at the 5' end, one can insert any desired sequence at the ends of
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the PCR cassettes, including spacers, restriction sites and ribosome binding sites.
The disadvantage is that PCR based cloning often results in sequences with
mistakes since Taq polymerase does not have the full array of error checking
machinery that many other DNA polymerases do.
The design for the first useful plasmid constructed, pDECO02, shown in
Figure 2-7, was intended to create a simplified sMMO operon that would only
express the three subunits of the hydroxylase. Upon induction of expression, the
E. coli cell culture color changed from an ordinary yellowish color to white.
Observation of the cells under the microscope revealed that the cells had large
white organelles taking up approximately 10-25% of the cell volume. These white
'bodies' were collected by cell lysis followed by centrifugation. The peptide
component of the aggregate was solublized with denaturants such as urea and
guanidinium hydrochloride, which showed the white material to be entirely
protein. SDS-PAGE analysis revealed that the protein was approximately 50%
hydroxylase peptides that had been misfolded and packaged as inclusion bodies.
Several lines of research were followed in an attempt to obtain active
hydroxylase from the pDECO02 plasmid. A system that produces inclusion
bodies can actually be an advantage if one is able to induce the collected protein
to refold into an active form. The packaging of the misfolded, expressed protein
allows it to be easily collected and purified away from other E. coli proteins.
Therefore, among the first experiments tried was to refold the hydroxylase via a
denaturation/renaturation cycle.
Use of hydrogen-bond disrupting salts such as urea and guanidinium
hydrochloride as a denaturant and then removing those salts by dialysis or
dilution did not afford any detectable soluble hydroxylase. This basic theme was
varied by changing the rate of dialysis/dilution, the presence of 'helper'
molecules such as thiols, Fe(III) or Fe(II), and the nature of the denaturant. A few
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detergents were screened, including N-lauroyl sarcosine, which is reported in the
literature as an excellent additive for refolding. The only method that exhibited
encouraging results was a technique labeled in the text above as sarcosyl pellet
solublization. The detergent N-lauroyl partially solublized the sMMOH
aggregate, but removal of the detergent induced the protein to precipitate out of
solution.
Since the sMMOH expresses and folds correctly in its native host, M.
capsulatus (Bath), it seems reasonable to conclude that there is either some factor
missing in the E. coli cytoplasm that is necessary for correct folding, or some
factor present in E. coli that is causing misfolding. It follows that an effort to
make the E. coli cytoplasm more like the M. capsulatus (Bath) cytoplasm might
cause the sMMOH to fold properly upon expression
One of the most basic differences between the sMMOH native expression
system and the designed system is the speed of expression. The native system
produces peptides slowly and steadily. The artificial system produces peptides
very quickly upon induction. One consequence of this difference is that there is a
large number of folding intermediates present in the cell after induction. One
might imagine that these folding intermediates might interact with one another,
forming long, polymeric, insoluble chains that would aggregate. This model for
inclusion body formation is the most prevalent one in the literature (43).
To reduce this folding intermediate problem, there are a number of
methods one can employ. Reducing the temperature, the IPTG concentration, or
both, can greatly reduce the amount of folding intermediates. This method often
works in the literature, but was unsuccessful in the sMMOH case. Changing
media content has also been successful in some cases, but was not useful for the
pDECO02 system.
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Changing the expression system has been helpful in producing soluble
protein from some inclusion body systems. In particular, with multisubunit
proteins, expression of the subunits individually can be of use. Accordingly, a
series of plasmids with the three subunits separated was constructed. Emphasis
was placed on expression of the MMOHx subunit, as there was the possibility of
it being useful on its own, even if expression of MMOH and MMOHy were
unsuccessful, or if reconstitution of the three subunits was not possible.
The first vector constructed, pDEC050, was designed to express the native
MMOHx. Not unexpectedly, the subunit was expressed as inclusion bodies. The
pDEC055 plasmid, constructed as a counterpart to pDEC050, was intended to
serve as a source of P and y subunit. The system failed to produce any proteins,
either soluble or insoluble. It seems most likely that the long space between the
pTrc promoter and the ribosome binding site, which was enforced by the linker
design, caused expression to fail. The plasmid pDEC060 was designed to attach
the pelB leader sequence onto the o subunit. The peiB sequence directs the
nascent polypeptide to be secreted into the periplasmic space. The periplasm is a
very different environment from the cytoplasm. The protein concentration is
lower, and the reduction potential is much more oxidizing. Unfortunately, no
soluble protein was afforded by this system.
The next vector made, pDEC070, was much more promising. The
construction of the vector expressed a fusion protein of the MMOHa with the
protein thioredoxin. Thioredoxin fusions are often quite soluble, and are popular
for use in solving inclusion body problems. In addition, the vector contained a
His6 site for simple purification and an S-Tag site for simple detection via
Western blot. Although approximately 90% of the expressed MMOHx-
thioredoxin was insoluble, the rest was soluble. It was quite unstable to protease
digestion, however, requiring the presence of the protease inhibitor Pefabloc SC
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(Boeringer-Mannheim). Purification on two successive nickel resin columns, with
a thrombin cleavage step between the two to separate the thioredoxin from the
MMOHa, afforded milligram amounts of pure a with approximately 2 irons per
subunit, as expected.
The expressed soluble MMOHa has no measurable hydroxylase activity,
however. The recombinant material also exhibited no mixed-valent or reduced
signal in the EPR, which are hallmarks of the native hydroxylase. It seems,
therefore, that the expressed material is folded only into a soluble form, not a
native one. It is not unusual to see small amounts of soluble, non-native,
misfolded material produced along with insoluble inclusion bodies. Samples of
MMOHa with no measurable properties are of limited utility.
Discussion and Conclusions
The work described above has taught us about the folding pathway of the
hydroxylase. The MMOHy subunit can refold into a soluble unit spontaneously,
as shown by refolding experiments. This result is not surprising, given
knowledge of the crystal structure. The MMOHy subunit caps the ends of the flat
hydroxylase molecule. A large proportion of its surface area is exposed to
solvent. This property contrasts with that of the MMOHa and MMOH3 subunits,
which have extensive contacts with one another. It seems likely that the a and P
subunits might have to fold together to reach a native conformation.
However, the folding of the MMOHa subunit must proceed normally to a
point. The material obtained from the inclusion bodies contained iron at an
approximate level of two irons per MMOHa. There are two domains in the a
subunit, domain 1 and domain 2 (16). It is possible that domain 1, which houses
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the iron site and that has the same fold as the soluble R2 subunit, folds well, and
that domain 2 does not.
Nevertheless, the hydroxylase does not fold into its native form in the E.
coli cytoplasm or under in vitro conditions. It seems that there is some specific,
unknown condition for correct folding that has not been met in the experiments
described above. There are several possibilities for the identity of this condition.
It may be some cytoplasmic physical condition, such as pH, salt concentration or
reduction potential, that was not reproduced in the conditions described above.
It may be that some specific M. capsulatus (Bath) "foldase" protein is necessary
for refolding, such as a chaperonin, or a disulfide bridge reducing protein. It
might also be that it is important for the sMMO polypeptides to be produced
with specific timing enforced by the M. capsulatus (Bath) ribosomal machinery.
This might be controlled by the spacing between the ribosomal binding sites and
the beginnings and ends of the sMMO genes, or by pauses induced by M.
capsulatus (Bath) codon preferences.
These possibilities suggest several possible methods for expression of the
hydroxylase. The possibilities for use of the E. coli organism as a host have not
been exhausted. Most of the simple "in vivo" experiments have been done. It
does not seem that the E. coli cytoplasm is a hospitable place for sMMOH
refolding. Refolding the collected hydroxylase inclusion bodies outside the cell is
still a viable possibility. The refolding work described above does not exhaust all
possibilities. A methodical search through possible refolding conditions, varying
pH, temperature, salt concentration, thiol concentration and reduction potential,
might result in native enzyme.
A second possibility is to use the existing system for producing soluble a
subunit and combine it with a system for producing P and y subunit. Since the
existing samples of the a subunit have 2 irons per peptide, as expected, this
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subunit is most likely partially assembled. It is possible that combining the
expressed a subunit with expressed or native p and y subunit would produce
active hydroxylase indistinguishable from the native material. It is not clear how
to recombine the subunits to form active material, because the native
hydroxylase cannot be disassembled except under highly denaturing conditions.
Nevertheless, this method is a possible avenue for hydroxylase expression.
A third possibility for expression of the sMMO hydroxylase is to extend
efforts into other organisms that may have cytoplasmic conditions more like M.
capsulatus (Bath). The psuedomonad Psuedomonas pudita would be a prime
choice, since the M. trichosporium sMMOH has been expressed successfully in it
already (38). The methylotrophic yeast Pichia pastoris is a possibility. It is a
valuable alternative in expression of proteins that have been problematic in E.
coli, and it may share C1 metabolic enzymes with M. capsulatus (Bath). A final
option is to express in M. capsulatus (Bath) itself. This is, by far, the most
challenging option, but it is the only organism that the sMMOH is known to fold
correctly in. It is challenging because little is known of its molecular biology,
other than it is very difficult to culture on solid media. In addition, there is the
problem of M. capsulatus (Bath) expressing large amounts of the native sMMOH
in addition to the mutant sMMOH. This problem could be solved by expressing
the pMMO, instead of the sMMO, by use of culture media containing copper.
Alternatively, one could produce M. capsulatus (Bath) hydroxylase knock-out
strains by using procedures described in the literature (37). If one assumes that
the technical problems associated with M. capsulatus (Bath) could be solved, then
use of a wide host range plasmid that contains both the genes necessary for its
own replication and the sMMO genes under an inducible promoter would be the
favored route for expression.
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Figure 2-1. Methylotrophs in the carbon cycle.
This schematic depicts the reclamation of small organic compounds into
the carbon cycle. The process begins with heterotrophic catabolsis of complex
hydrocarbons, typically biological in origin, to small molecules. The products of
this process descend to lower layers of the soil where the dioxygen concentration
is low. Organisms called methanogens reductively metabolize the small organic
waste products to methane, generating energy for themselves. The methane gas
produced diffuses towards the surface. Where the dioxygen concentration is
high, the methylotrophs can subsist on this methane as a source of carbon and
energy, releasing carbon dioxide as a waste product. Thus, carbon is returned to
the large pool of CO 2 in the atmosphere.
This cartoon shows one location where methylotrophs can prosper. Any
space where methane and oxygen coexist, such as marshlands or geothermal gas
vents, could be imagined as a home for these unique organisms.
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Figure 2-2. Metabolism of methane in M. capsulatus (Bath).
The first step, oxidation of methane to methanol, is catalyzed by MMO.
One NADH molecule must be consumed for every turnover. The second step,
oxidation of methanol to formaldehyde, is catalyzed by methanol
dehydrogenase. A NADH equivalent, PQQH2, is generated by this reaction,
making the first two reactions energy neutral up to this point. At the
formaldehyde step, the organism can choose between assimilation of the carbon
or generation of energy by oxidizing the CH 2O to CO 2 via formaldehyde
dehydrogenase and formate dehydrogenase.
A more detailed account of this metabolic pathway along with related
reactions can be found at <http://www.expasy.ch/cgi-bin/show-image?D5>.
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Figure 2-3. Native sMMOH PAGE.
An SDS-PAGE gel showing the purified native sMMOH from M.
capsulatus (Bath). The samples vary in quality, and represent a range of the purest
protein available at the time.
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Figure 2-4. Sample Western Blot.
An SDS-PAGE gel with a matched Western blot showing typical results
obtained. The sMMOHx variation shown in the Figure is a sMMOHX-
thioredoxin fusion protein discussed later in the chapter. The additional proteins
visible in the hydroxylase lane of the Western blot are due to strong interactions
between the hydroxylase impurities and antibodies against those impurities in
the sMMOH polyclonal antiserum.
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Figure 2-5. PCR of the sMMOH genes.
Agarose gel showing the results of PCR amplifications of the mmoX, mmoY
and mmoZ genes from M. capsulatus (Bath) genomic DNA.
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Figure 2-6. Construction of pDEC002.
PCR cassettes for the mmoX, mmoY and mmoZ genes were inserted one at a
time into the superlinker plasmid pSL301. The mmoY* gene was generated from
an incorrect PCR primer pair that was designed before it was discovered that the
published gene sequence of the mmoY gene contained a frame shift mistake (see
chapter one). A new primer pair based on the correct sequence was designed and
the new mmoY gene was inserted into the pSL301-mmoXY*Z plasmid. The
assembled artificial sMMOH operon was excised and ligated into the pTrc99A
gene to make pDEC002.
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Figure 2-7. Structure of pDEC002.
Expression of the mmoX, mmoY and mmoZ genes are controlled by the
pTrc promoter, based on a combination of the E. coli lac and trp promoters.
Immediately following the mmoZ gene is a small multiple cloning site and the
rmB transcription termination region, designed to prevent run-through
transcription. Additional features of the plasmid include the p-lactamase gene for
ampicillin resistance, the pBR322 origin of replication, and a copy of the lacIq
gene for production of the lac repressor and successful expression in lac- hosts.
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Figure 2-8. Expression of sMMOH genes in E. coli results in inclusion bodies.
An SDS-PAGE gel showing the results of expression of the sMMOH genes
in pDECO02 in E. coli JM105. The sMMOH subunits are clearly visible in only the
insoluble lanes. The dark band near the MMOHP subunit in the soluble fractions
is a native E. coli protein present in controls.
150
Figure 2-9. Attempted refolding of expressed, insoluble sMMOH under a
variety of conditions.
An SDS-PAGE gel shows the results of several refolding experiments with
two different iron sources. Note that the y subunit refolds.
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Figure 2-10. Expression of sMMOH from pDECO02 by using a sarcosyl lysis
procedure.
An SDS-PAGE gel shows the results of lysing the E. coli containing
expressed sMMOH inclusions in the presence of sarcosyl detergent. The photo is
a compilation of several lanes from a single gel.
154
N~ ~>
4~ N
'~0 ~
I
Figure 2-10
Figure 2-11. Attempted reconstitution of the expressed, insoluble sMMOH by
using detergents.
An SDS-PAGE gel shows the results of reconstituting the expressed
sMMOH in a variety of detergents.
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Figure 2-12. Attempted reconstitution of the expressed, insoluble sMMOH by
using sarcosyl detergent.
An SDS-PAGE gel shows the results of reconstituting the expressed
sMMOH with sarcosyl detergent. Note that the sarcosyl resolublized a portion of
the sMMOH, but removal of the sarcosyl resulted in the reprecipitiation of the
protein.
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Figure 2-13. Expression by using the pDECO10 plasmid in E. coli.
An SDS-PAGE gel shows the result of expression of the sMMOH and B
genes in E. coli. Note that mmoZ does not seem to be expressed in this system.
The soluble protein near the a subunit is not MMOHa, but an E. coli protein.
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Figure 2-14. Construction of pDECO50 and pDEC055.
pDECO50 and pDECO55 were constructed by using similar methods. A
fragment (either mmoYZ or mmoX) was cut out of pDEC002. The remaining
plasmid was spliced together by using a short linker. These linkers were
designed to remove the single EcoR I site in pDECO02, and insert a BamH I site in
its place. This allowed for easy screening of the resulting plasmids.
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Figure 2-15. Structure of pDECO5O and pDECO55.
These plasmids are very similar to their parent pDECO02, including the
pTrc promoter, the rmB terminator, ampicillin resistance, and a copy of the lac
repressor. pDECO50 was intended for expression of the mmoX gene, and
pDECO55 was intended for expression of the mmoY and mmoZ genes.
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Figure 2-16. Construction of pDEC060 and pDEC070.
The plasmid pDEC060 was constructed by excision of the mmoX gene
from pDECO50 and insertion into the pET20b plasmid. Use of the Nco I site
allowed fusion with the pelB tag. Due to the design of the pDECO50 plasmid,
there are nine amino acids in between the pelB and mmoX genes that are part of
neither sequence.
The plasmid pDEC070 was constructed by designing a new set of PCR
primers tailored for the pET32a plasmid. These primers were used to amplify the
mmoX gene from the pCH4 cDNA copy of the sMMO operon. The mmoX PCR
product was directly cloned into pCRII. This procedure was done to solve to
problem often seen in earlier cloning work of cutting restriction sites close to the
end of PCR products. The mmoX gene was excised from pCRII-mmoX and ligated
into the pET32a plasmid.
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Figure 2-17. Structure of pDEC060 and pDEC070.
The pDEC060 plasmid's major feature is a fusion with the pelB leader
sequence. This allows proteins that are attached to it to be exported to the
periplasm. This can be advantageous in a variety of ways. The periplasm in
different from the cytoplasm, in that the protein concentration is lower and the
reduction potential is oxidizing. Periplasmic expression also allows for easy
harvest of the expressed protein, as the cell wall can be broken via a simple
freeze/thaw cycle.
The pDEC070 plasmid has several useful features. It fuses the mmoX gene
with the thioredoxin gene. This feature is specifically designed to help solubilize
difficult to fold proteins. In between the mmoX and trxA genes are a number of
small useful sequences, including a His6 tag for easy purification, an S-Tag for
easy Western blots, and thrombin and enterokinase cleavage sites to remove the
thioredoxin fusion at will.
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Figure 2-18. Expression of sMMOH genes from pDEC050 and pDEC055.
An SDS-PAGE gel shows the results of expression of the pDECO50 and
pDECO55 plasmids in E. coli. The pDECO50 plasmid exhibits strong expression of
the a subunit in an insoluble form. The pDECO55 plasmid does not show any
expression of the P and y subunits at all. This indicates that the space between the
promoter and the RBS of the mmoY gene, which is enforced by the linker design,
may be too long.
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Figure 2-19. Periplasmic expression of the sMMOHa from pDEC060.
An SDS-PAGE gel shows the results of expression of the pDEC060
plasmid in E. coli. The pelB-tagged c subunit did not fold correctly, and was
found in the insoluble fraction, despite its direction to the periplasm. No soluble
protein was visible in the soluble fractions.
172
4 4$i 9
mmC
Figure 2-19
Figure 2-20. Expression of the thioredoxin-a subunit fusion protein from
pDEC070.
An SDS-PAGE gel shows the results of the expression of the pDEC070
plasmid in E. coli. At 37 *C the thioredoxin fusion protein is expressed as
insoluble inclusion bodies.
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Figure 2-21. Purification of the thioredoxin-x subunit fusion protein.
An SDS-PAGE gel and Western blot show the purification of the
thioredoxin fusion protein from the bulk of the soluble E. coli proteins by using a
Ni2 .-NTA column.
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Figure 2-22. EPR spectrum of putatively Fe(II) Fe(III) thioredoxin-a subunit
fusion protein.
a. EPR spectrum of 150 gM thioredoxin fusion protein prepared under
conditions expected to produce mixed-valent diiron center at 7.2 K. b. EPR
spectrum of native sMMOH prepared under conditions expected to produce
mixed-valent diiron center at 8.0 K. Both spectra: 100 kHz modulation frequency,
6.67 G modulation amplitude, 9.41 GHz microwave frequency, 1 mW microwave
power. The signals at g~4.3 and g=2.00 are due to ferric iron impurities and
protein-based radical induced by the chemical reduction, respectively. The
g=1.93, 1.90, 1.85 signal is due to the antiferromagnetically coupled S=1/2 Fe(II)
Fe(III) center in the hydroxylase (45).
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Chapter Three
Reactions of Nitric Oxide with the Reduced Non-Heme Iron Center
of the Soluble Methane Monooxygenase Hydroxylase
Introduction
The soluble methane monooxygenase (sMMO) enzyme system in
methanotrophic bacteria catalyzes the oxidation of methane to methanol and
water by using dioxygen as an oxidant at a non-heme carboxylate-bridged diiron
center (1-5). One atom of the dioxygen molecule is incorporated into the product
alcohol and the other is released as water. Two electrons from NADH and two
protons are also required. The controlled oxidation of hydrocarbons by this and
similar systems is a topic of considerable current interest.
The sMMO system has three known protein components. The hydroxylase
(H) is a homodimer (aj2 Y2) that contains a non-heme diiron center in each of its
a subunits. The iron center is the locus of dioxygen activation and methane
hydroxylation. The reductase (R) is responsible for transferring electrons from
NADH through protein-bound FAD and [2Fe-2S] centers to the diiron center in
the hydroxylase. A third component, protein B or the coupling protein, serves to
couple this electron transfer to alkane hydroxylation.
The catalytic cycle of the hydroxylase enzyme has been examined in detail
by using a variety of rapid kinetics methodologies, including optical stopped-
flow and freeze-quench M6ssbauer spectroscopy. Typically, the iron center is
chemically reduced to the diiron(II) state, designated Hred, and mixed rapidly
with solutions containing dioxygen. The first well characterized intermediate
after Hred is Hperoxo (6, 7), assigned as a (g-1,2-peroxo)diiron(III) species through
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spectroscopic comparison with crystallographically characterized model
compounds (8-10). The Hperoxo intermediate spontaneously transforms into
intermediate Q (7, 11), which has been assigned a di(g-oxo)diiron(IV) structure
based on EXAFS evidence (12), although other interpretations of the data are
possible (1). Intermediate Q reacts with alkane substrates to form hydroxylated
products, returning the catalytic center to its resting, diiron(III) state, designated
H0 X.
The role of protein B is not well understood. The catalytic cycle described
above does not take place if protein B is absent. The diiron(II) center is instead
oxidized to the diiron(III) state without observable accumulation of the Hperoxo
and Q intermediates. Under steady state conditions, protein B from the M.
capsulatus (Bath) sMMO system has a dramatic effect on turnover (13, 14). When
it is not present, hydroxylation of products is completely uncoupled from
dioxygen and NADH consumption. Instead, dioxygen is reduced to water. As
protein B is added to the system, the coupling of hydroxylated product
formation to dioxygen consumption increases. At a 1:1 ratio of protein B to
hydroxylase the system is fully coupled. As the ratio of protein B to hydroxylase
increases beyond 1, the hydroxylation reaction is inhibited. These observations
are consistent with protein B having a role as a regulatory protein. The coupling
protein also has a direct effect on the iron center. The presence of protein B
causes the g = 16 integer spin EPR signal of Hred from M. trichosporium OB3b to
become sharper and more intense (15). Magnetic circular dichroism experiments
indicate that protein B effects a major coordination change at one of the iron
atoms in the active site (16, 17), the details of which are obscure. Knowledge of
these changes is crucial both structurally modeling and comprehending the
mechanism of the sMMO system.
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Nitric oxide is a useful surrogate for dioxygen (18) and reacts similarly
with iron to afford complexes having useful spectroscopic properties. Species
produced by the reaction of iron(II) with nitric oxide typically are brightly
colored, S = 3/2 systems (19-21) with characteristic EPR signals (22-24), and are
designated as {Fe(NO)}7 (21), where the superscript refers to the sum of d
electrons from iron and n' electrons from the NO molecule.
Nitric oxide has been useful as a probe of non-heme, carboxylate-bridged
diiron centers. In hemerythrin (Hr), one NO molecule binds to a single iron atom
(25, 26). The resulting {Fe(NO)}7 center couples antiferromagnetically with the
other high-spin iron(II) center to form an EPR-active, S = 1/2 spin system. The
mode of NO binding was proposed to be very similar to that of 02, with the
uncoordinated oxygen atom of the NO ligand forming a hydrogen bond with the
hydroxide bridge present in deoxyhemerythrin. This proposal was supported by
a shift in the Raman spectrum due to changes in the Fe-N-O bending mode
upon deuteration of the bridge. In the R2 subunit of ribonucleotide reductase, a
more complex, heterogeneous reaction was observed (27). Addition of NO to the
diiron(II) center of this protein afforded a complex having optical features at 450
and 620 nm. M6ssbauer spectra of the product revealed a mixture comprising
77% of a diiron dinitrosyl species, [{Fe(NO)}7]2, 13% of mononuclear {Fe(NO)}7,
and 10% of an unidentified species. The two S = 3/2 {Fe(NO)}7 centers in the
diiron dinitrosyl adduct were antiferromagnetically coupled to form an EPR-
silent species, which decomposed with first order kinetics, reductively coupling
the two NO molecules to form N 20 and oxidized RNR-R2. This diiron dinitrosyl
species was proposed to be a model of the peroxo intermediate in the RNR-R2
reaction cycle. The spectroscopic properties of these and selected model
compounds with carboxylate-bridged, non-heme diiron centers complexed with
NO are listed in Table 1.
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The present article describes a study of the reactions of NO with the
reduced diiron center of the sMMO hydroxylase from M. capsulatus (Bath). These
experiments afford the opportunity not only to model the 02 binding step, but
also to probe the role of protein B. The results provide important information
about how the coupling protein can alter the dinuclear iron center for reaction
with dioxygen.
Experimental Procedures
Preparation and Purification of sMMO Hydroxylase (H) and Protein B.
Samples of sMMO hydroxylase and of 57Fe-enriched sMMO hydroxylase were
prepared from Methylococcus capsulatus (Bath) as previously described (28).
Protein B was prepared from a cloned source in E. coli as reported (29). Purity of
the components was assured by SDS-PAGE electrophoresis. Specific activity and
iron content were measured as described and were in the range of 250-350 nmol
propylene formed mg-1 min-1 and 3.4-3.7 Fe/protein, respectively.
Preparation of Diiron(II) sMMO Hydroxylase (Hred). Purified sMMOH
samples were prepared in 25 mM MOPS pH 7.0 with stoichiometric amounts of
the mediator methyl viologen. The sample was degassed by 15-20 cycles of
vacuum evacuation followed by argon backfilling. A degassed solution of ~10
mM sodium dithionite in 50 mM MOPS (pH 8.6) buffer was prepared and used
to titrate the protein solution until the methyl viologen changed from yellow to
blue. A 30 min time period was sufficient for complete reduction. The sample
was then anaerobically dialyzed against two successive 500 mL volumes of 25
mM MOPS pH 7.0 to remove the mediator and reductant.
Addition of NO Gas. Hred samples were prepared and placed in vials sealed
with rubber septa both with and without the presence of 2 equiv of protein B.
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Nitric oxide (99+%, Matheson) was purified by passage through a concentrated
NaOH solution to remove NO2. The NO gas was passed over the protein
solution for 5 min with manual agitation to ensure complete reaction. A change
from colorless to green-brown was immediately observed. The NO stream was
replaced by an argon stream for 10 min to remove excess NO. Samples for EPR
and M6ssbauer were anaerobically transferred to appropriate cells and frozen in
liquid nitrogen approximately 45 min after NO addition.
Addition of NO via NONOates. NONOates are compounds that are stable at
high pH, but decompose to NO gas at pH 7 (30, 31). They are useful as a means
for delivering precisely known amounts of NO in aqueous solutions. NONOates
are stored as concentrated stocks in 10 mM NaOH. The rate of decomposition
was determined by introducing a small volume of concentrated NONOate into a
25 mM MOPS pH 7.0 solution and observing the disappearance of the NONOate
UV absorption in mock reactions. This known rate of decomposition was used to
determine how much NO is present in a protein solution at any given time after
introduction of the NONOate.
Hred samples were prepared and placed in septum-sealed vials both with
and without the presence of 2 equiv of protein B. A small amount (< 1% of
sample volume) of concentrated diethylamine-NONOate (Cayman Chemicals)
was added, and the reaction was allowed to proceed until the desired amount of
NO was generated. Samples were frozen in EPR tubes or M6ssbauer cells.
Stopped-flow Spectrophotometry. Stopped-flow experiments were performed
to observe the reaction of Hred with nitric oxide both with and without the
presence of 2 equiv of protein B. This ratio of B to H was chosen for direct
comparison with previously reported stopped-flow studies with dioxygen (11).
Protein samples, typically 50-150 gM in Hred, were loaded anaerobically into
Hamilton gastight syringes with Luer-lock fittings. Saturated NO solutions were
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prepared by first saturating 25 mM MOPS pH 7.0 solutions with argon gas to
remove 02. The solutions were cooled to 4 *C and NO gas was bubbled through
them for 15-30 min, resulting in a solution of approximately 2.9 mM NO. This
solution was diluted to the desired NO concentration with anaerobic buffer and
transferred to a Hamilton gastight syringe. Both the protein- and gas-containing
syringes were used to load the drive syringes of a HiTech SF61 DX2 stopped-
flow instrument. Both syringes were allowed to equilibrate in a constant
temperature bath for 15-30 min before recording data. Two detection systems
were used. A HiTech UV-vis diode array spectrophotometer collected data over
a wide range of wavelengths. A photomultiplier tube and monochrometer were
used to collect data at single wavelengths.
To examine the effects of methane substrate, the NO containing buffer was
further treated. An anaerobic methane stock solution was prepared by bubbling
argon followed by methane through a septum sealed vial of 25 mM MOPS pH
7.0. An aliquot of this solution was mixed in a 1:1 ratio with NO-saturated buffer
before being loaded into the stopped-flow syringe.
Rapid Freeze-quench Mdssbauer Sample Preparation. All freeze-quench
samples were made as described in detail elsewhere (32). Rapid freeze-quench
samples were performed with an Update instruments Model 705A computer and
syringe-ram apparatus. Protein solutions were 1.1 mM in Hred. NO solutions
were prepared by purging a 25 mM MOPS buffer sample with argon and
allowing it to come to equilibrium in a chamber filled with 1 atm of NO gas at
room temperature. The final NO concentration was approximately 1.9 mM. The
reactants were loaded into RFQ syringes and allowed to cool to 4 *C in an
ice/water bath. The protein and gas solutions were mixed rapidly, allowed to
react for various fixed time periods governed by the length of tubing between the
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mixing chamber and the nozzle, and then sprayed into isopentane at -140 *C. The
resulting snow was packed into Delrin® Mdssbauer sample holders.
Rapid Freeze-quench EPR Sample Preparation. Rapid freeze-quench samples
were prepared by using an Update Instruments Model 715 syringe-ram
apparatus. Solutions of proteins and NO gas were prepared in a manner similar
to that described above for the stopped-flow procedures. Hred concentrations
were approximately 300 gM. The reactants were loaded into gas tight syringes
and cooled to 4 *C. The solutions were mixed rapidly, allowed to react for fixed
time periods (28 ms - 60 s) in the aging tubing, and then sprayed into isopentane
at approximately -140 *C. The resulting snow was packed into quartz EPR tubes.
EPR Measurements. X-band EPR spectra were measured on a Bruker ESP
300 spectrometer equipped with an Oxford EPR 900 liquid helium cryostat.
Spectra were recorded under the following conditions: temperature, 4.2 - 8.0 K;
microwave frequency, 9.41 - 9.65 GHz; microwave power, 10 RW - 158 mW;
modulation frequency, 100 kHz; modulation amplitude, 6.64 Gauss. Specific
conditions are reported on the individual spectra. EPR quantitation was
performed by double integration under nonsaturating conditions using 0.960
mM CuSO4, 1 M NaClO 4 as a standard. Quantitations were corrected for g-value
anisotropy and spin. EPR power saturation data were collected by measuring
signal intensity as a function of the applied microwave power over a range of
four orders of magnitude.
Mdssbauer Measurements. M6ssbauer spectra were collected by using either
a weak-field spectrometer equipped with a Janis 8DT variable-temperature
cryostat or a strong-field spectrometer outfitted with a Janis 12 CNDT/SC
SuperVaritemp cryostat encasing an 8 T superconducting magnet. Both
spectrometers were operated in a constant acceleration mode in a transmission
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geometry. The centroid of a room temperature iron foil spectrum was used as the
zero velocity reference point.
Nitrous Oxide Detection by Gas Chromatography. Solutions of Hred both with
and without 2 equiv of protein B were prepared in 1 mL septum-sealed vials.
These samples were -300 gM in Hred and 300 pL in volume. A saturated 2.9 mM
NO buffer sample was prepared at 4 *C as described above. A 100 gL aliquot of
the NO buffer was added to the protein sample. At 5 min and 30 min intervals
after NO addition, 50 gL headspace aliquots were removed and injected on a
Hewlett-Packard 5890 gas chromatograph equipped with a 6 ft. packed Haysept
column and a thermal conductivity detection system. The column He gas flow
rate was 21-23 mL/min at 35 'C. Under these conditions, retention times for
various gases were determined to be ~1.3 min for N2 and NO and 5.1-5.2 min for
N20. N2O standards were prepared by assembling mock reaction vials with BSA
at w/v concentrations equivalent to the hydroxylase in 25 mM MOPS buffer.
Known amounts of N20 were injected into these vials and they were subjected to
the same 5 min and 30 min 50 gL headspace analysis as the Hred+NO samples.
Several N 20 vials were analyzed and a standard curve was constructed.
Results
Preparation of NO complexes of Hed and Hred+2B. Addition of NO gas to
samples of Hred and Hred with two equiv of protein B (Hred+2B) immediately
afforded greenish brown solutions, henceforth designated Hred+NO and
Hred+ 2 B+NO, respectively. The NO addition method was varied and included
direct addition of excess NO gas, direct addition of limited quantities of NO gas
by a gas-tight Hamilton syringe, addition of NO via a NONOate precursor and
addition of NO by NO-saturated buffer. No appreciable difference was observed
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in the resulting optical or EPR spectral results for samples generated by these
different methods.
Optical Absorption Spectra. The optical spectrum of the Hred+NO adduct is
shown in Figure 1, with maxima at 450 nm and 620 nm. The extinction coefficient
at 450 nm was determined to be -740 M-1 cm-1. The spectrum of the
Hred+ 2B+NO complex was nearly identical, the only difference being a small
decrease in e to approximately -700 M-1 cm-1.
These spectra are quite similar to those of the dinitrosyl adduct of [Fe 2(R-
XDK)(k-0 2CPh)(ImH)2(O2CPh)(MeOH)] (33, 34), also shown in Figure 1. This
compound has a ligand composition identical to that of Hred and displays similar
reactivity toward dioxygen. Colored intermediates with characteristic peroxo-to-
iron charge transfer bands form rapidly upon reaction with dioxygen. This
compound forms a dinitrosyl adduct upon reaction with NO, as established by
M6ssbauer and EXAFS spectroscopy (34).
Missbauer Analysis of Hred+NO and Hred+2B+NO Samples. Figure 2 shows
the zero-field M6ssbauer spectra recorded at 4.2 K of samples of Hred and Hred
with 2 equiv. of protein B that has been allowed to react with NO for
approximately 45 min. Several species can be identified, the relative proportions
of which are summarized in Table 2. Both unreacted Hred and H0 x can be
identified in the spectra according to their previously identified characteristics
(11, 28). Species consistent with mononuclear {Fe(NO)}7 and mononuclear Fe(III)
were identified on the basis of their isomer shift and high field M6ssbauer
properties. A diamagnetic species with M6ssbauer parameters consistent with
the dinitrosyl adduct of Hred, termed Hdinitrosyl, was detected. Finally, an
unknown diamagnetic species with a very low isomer shift, 0.2 mm/s, was
identified. This low isomer shift is consistent with an Fe(IV)-containing
compound, such as species containing an Fe(NO)2 unit.
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EPR Analysis of Hred+NO and Hred+2B+NO Samples. Figure 3 shows the X-
band EPR spectra of the Hred+NO and Hred+2B+NO adducts at 4-5 K. The major
signal in the Hred+NO spectra has g = 4.08,4.02 and 2.00 and arises from an S=
3/2 species consistent with mononuclear {Fe(NO)}7 as observed in the
M6ssbauer spectra described above. Determination of the spin concentration of
this signal from several independent samples showed that it represents 20-30% of
the total iron in the sample. The half-saturation value, P 1/2, for this {Fe(NO)}7
center was determined to be -7 mW. Interestingly, this signal splits into at least
three species with slightly different rhombicities (g = 4.08, 4.02; g = 4.15, 3.95; and
g = 4.22, 3.86) upon addition of protein B. This splitting was obtained by addition
of protein B either before or after NO exposure. Mononuclear Fe(III) associated
with exogenous iron impurities is present, also consistent with the Mossbauer
samples, exhibiting a g = 4.3 high spin ferric signal. Spin quantitation of this
signal reveals that it represents 2-6% of total iron in the sample.
Stopped-flow Analysis of the Hred+NO and Hred+2B+NO Reaction. Stopped-
flow optical spectrophotometry was used to analyze the kinetics of formation
and decay of species formed in the reaction of NO with the reduced diiron center
of the hydroxylase. As shown in Figure 4, an optical signal with maxima at 450
nm and 620 nm builds up rapidly upon mixing, maximizing at ~150 ms. After
150 ms, the signal decays slowly until all visible changes stop, approximately 20-
30 min after NO addition. At that time, the signal had approximately half of its
150 ms maximum intensity. The buildup was best fit by a biphasic A + B + C
model that, at 4 *C, had rate constants k, = 78 ±6 s-1 and k2 = 18 ±2.7 s-1. Global
analysis of the stopped-flow data revealed that the spectra of species B and C in
the two phase model were nearly identical, the only difference being a 1-2%
decrease in extinction coefficient for B. The decay of the optical signal could not
be fit well to any specific model, indicating that it is a complex process
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comprising various component reactions. First-order fits approximating the
decay at 4 *C produced a rate constant of 0.06 ± 0.02 s-1. Variation of the NO
concentration over a 10-fold range did not appreciably change the observed rate
constants. All stopped-flow experiments subsequently reported here were
conducted with at least a 20-fold excess of NO. The temperature dependence of
the rate constants for buildup of the optical species was measured. Eyring plots
of these data, shown in Figure 5, yielded the activation parameters shown in
Table 3. A simulation of the time-dependent growth and decay of species formed
in the Hred+NO reaction, obtained by using the rate constants obtained from
stopped-flow data, is presented in Figure 6.
The reaction of NO with the reduced hydroxylase and two equiv of
protein B was also examined by stopped-flow spectroscopy. The optical signals
detected were essentially identical to those in the Hred+NO reactions, the major
difference being a small diminution in observed extinction coefficient as
described above. The buildup of this species could, in contrast with the Hred+NO
reactions, be fit well by a single exponential buildup. At 4 'C, the rate constant
was determined to be k = 26 ±0.8 s-1. The decay, as in the Hred+NO case, was too
complex to be fit satisfactorily by a simple model. First order approximation of
the decay yielded a rate of 0.05 ± 0.02 s-1, within error the same value as for the
Hred+NO reaction. Temperature-dependent studies of this reaction produced
activation parameters listed in Table 3, with the Eyring plots of these data shown
in Figure 5.
The kinetics of the Hred+NO and Hred+ 2B+NO reactions were also
examined in the presence of methane. The optical bands that appeared were
identical to those formed without methane present. The rates for both reactions
could be fit well by first order equations.
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Rapid Freeze-Quench EPR Characterization of Hred+NO Reaction Species.
Freeze-quench samples of the Hred+NO reaction were collected at 28 ms, 158 ms,
1 s and 60 s. Spectra taken from those samples are shown in Figure 7. The signal
corresponding to the S = 3/2 {Fe(NO)}7 species can be seen growing in at 28 ms,
achieving its maximal value in the 158 ms sample. Fits of these data indicate that
the first order rate constant for the buildup of this signal is 10-20 s-1 at 4 *C. Its
concentration, 27% of the total amount of iron centers in the sample, does not
change within the error limits of the experiment after this time point (see inset,
Figure 7). The signal at g = 1.97 is due to free NO in solution, and can be
observed to decrease in intensity during the time course. In the 60 s sample, a
signal at g = 2.04 has appeared. This signal is most likely due to a small amount
of some S = 1/2, Fe(NO)2 species. It accounts for <2% of total iron in the sample.
Missbauer Characterization of Hred+NO Reaction Species. The protein
concentration used in these experiments was much higher than in other
Hred+NO work, in order to optimize the signal-to-noise ratio obtainable with
M6ssbauer spectroscopy. A consequence of this limitation is that the NO
concentration (-1.9 mM) is substoichiometric with respect to the amount of iron
(-3.9 mM). As a result, more than 50% of the hydroxylase remains in the reduced
state. In addition, the rates of the NO reactions cannot be directly compared with
those obtained in the stopped-flow and EPR freeze-quench experiments, because
those data were obtained under pseudo-first-order conditions where NO was in
great excess.
Figure 8 shows the Mossbauer spectra of the reaction of Hred with NO at
three different times after mixing, and Table 4 contains the M6ssbauer
parameters used for the fits to the data. Reactions were quenched at 61 ms, 126
ms, and 440 ms. The major component of all the spectra is a quadrupole doublet
attributable to unreacted Hred. A -10% amount of H0 x can be seen in all samples
191
that cannot be reduced, as previously observed for the M. capsulatus (Bath)
hydroxylase (11). These two species can be identified in the spectra according to
their previously identified characteristics (11, 28). A species corresponding to
mononuclear {Fe(NO)}7 develops very quickly, reaching its maximal
concentration before 61 ms. It does not decay after 440 ms, in accord with the
freeze-quench EPR data. A species with M6ssbauer parameters characteristic of
Hdinitrosyl also forms very quickly, consistent with the stopped-flow evidence.
This species decays to approximately 80% of its maximal value at the 440 ms time
point. This rate of decay is slightly faster than that observed in the stopped-flow
experiments. Such a difference might arise if the "unidentified" decay product of
Hainitrosyi has optical properties similar to that of other iron nitrosyl species, a
likely possibility. Thus the measured decay rate of Hainitrosyi as observed by
optical stopped-flow spectroscopy may be inaccurate owing to the buildup of
other colored components. The M6ssbauer parameters of a decay product from
the Hred+NO reaction at the 440 ms time point suggest that it may be some
Fe(NO)2 containing species.
The M6ssbauer freeze-quench work serves to identify Hainitrosy species as
the diamagnetic reaction component that forms and decays slowly in the
stopped-flow experiment (Figure 6). It also supports the rapid freeze-quench
EPR data indicating that a mononuclear {Fe(NO)}7 species develops very quickly
upon reaction of NO with Hred and does not decay.
Decay of Hinitrosyl to N2 0. The dinitrosyl adduct of the diiron center in the
R2 subunit of ribonucleotide reductase decays slowly with a first order rate
constant of ~0.013 min- to R2met and N20 (27). To determine whether the sMMO
dinitrosyl adduct undergoes similar chemistry, the headspace of a Hred+NO
sample was analyzed for N20 by gas chromatography. Samples taken at both 5
and 30 min after exposure to NO contained 0.06-0.12 equiv of N20 per
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hydroxylase diiron center. Similar samples taken of the Hred+ 2 B+NO reaction
contained 0.10-0.16 equiv of N 20 per hydroxylase diiron center. One of the decay
pathways of the Hdinitrosyi species is reductive elimination of N 20, most likely
affording Hox as a product.
Discussion
Reaction of Reduced Hydroxylase with NO to Form a Diiron Dinitrosyl Species.
Nitric oxide reacts with the reduced diiron center in the sMMO hydroxylase to
afford a diiron dinitrosyl species referred to as Hdinitrosy. As indicated in Figure
9, this EPR-silent [{Fe(NO)}7]2 unit accounts for a majority of the iron, the
remainder being mononuclear (vide infra). The Hdinitrosy intermediate models
Hperoxo in the sMMO reaction cycle. Its two {Fe(NO)}7 centers
antiferromagnetically couple to afford a diamagnetic ground state.
The spectroscopic properties of Hdinitrosyl were revealed by stopped-flow,
RFQ EPR and RFQ M6ssbauer experiments. When Hred is allowed to react with
NO, an optical spectrum rapidly grows in, maximizes after approximately 150
ms, and subsequently decays. The optical spectrum closely resembles those of
diiron dinitrosyl model complexes (34) and a similar dinitrosyl adduct of the
ribonucleotide reductase R2 protein (27). The optical data are therefore consistent
with formation of a diiron dinitrosyl unit, but alone are insufficient to prove that
assignment.
Rapid freeze-quench M6ssbauer data indicate that only two species
containing iron-nitrosyl moieties form within the first 500 ms of reaction. The
isomer shifts and quadrupole splitting parameters are consistent with the
formation of Hdinitrosyl and a mononuclear {Fe(NO)}7 center. Rapid-freeze-quench
EPR as well as Mbssbauer spectroscopy establish that the mononuclear {Fe(NO)}7
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unit forms in the first 100 ms after NO addition and does not decay even after 60
s of reaction. The RFQ M6ssbauer data reveal that the species assigned as
Hdinitrosyl decays after 150 ms. Since the stopped-flow experiments indicate that
the optical bands at 450 and 620 nm bands also decay after 150 ms of reaction, it
can be concluded that Hdinitrosy contributes significantly to the observed optical
signals.
Although it is possible that the mononuclear {Fe(NO)}7 species also
absorbs at 450 and 620 nm, its contribution is likely to be minimal. The EPR
spectra reveal that most of the iron is diamagnetic. Moreover, both the Hdinitrosy
and mononuclear {Fe(NO)}7 species appear, from all available data, to build up
during the first 200 ms of reaction. If the contribution from a mononuclear
{Fe(NO)}7 species were similar to that of Hdinitrosy, one would expect to be able
to distinguish the two formation rates kinetically. Instead, the stopped flow data
could be fit well to simple A 4 B (Hred+2B+NO) and A + B 4 C (Hred+NO)
models (vide infra). Fits to A + B, A 4 C buildup kinetics could not account for
the data. It is therefore likely that only one major optical species forms in the
Hred+NO reaction. Since Hdinitrosyl is a significant contributor to the optical
signals seen in the stopped-flow spectroscopic experiments (vide supra), we
conclude that Hdinitrosyl is the major component.
A Mononuclear (Fe(NO))7 Minority Species in the Hred+NO Reaction.
Approximately 15-30% of the protein active sites react with NO to afford a
paramagnetic, S = 3/2 {Fe(NO)}7 unit. This species probably forms in the active
site of the hydroxylase, because its EPR characteristics are affected by the
presence of protein B (vide infra). We considered the possibility that the
{Fe(NO)}7 EPR signal might arise by reaction of the active sites to eject one iron
atom, leaving the second to react with NO to form a mononuclear species. Such a
mechanism is unlikely, however, since the iron atoms are well coordinated by
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protein ligands and not expected be extruded from the active site simply by
addition of nitric oxide. Moreover, the iron content of the hydroxylase was
determined both before and following NO treatment, and no metal was lost as a
result of the reaction (data not shown). The sMMO hydroxylase as currently
isolated from M. capsulatus (Bath) has 3.4-3.7 iron atoms per molecule, fewer than
the expected number of 4 if all sites were fully occupied. The absence of one iron
atom from 20% of the active sites would amount to a 10% deficiency of total iron,
consistent with the measured amount of iron in the protein. We therefore
attribute the {Fe(NO)}7 signal to mononuclear resulting from iron-depleted
enzyme. Heterogeneity in the sMMO hydroxylase as isolated has previously
been noted in kinetics and spectroscopic experiments (11).
Effects of Protein B on the Mononuclear (Fe(NO))7 Species. The presence of
protein B causes the S = 3/2 EPR signal of the {Fe(NO)} species to split into three
signals arising from three species with slightly different rhombicities. This
phenomenon can be explained by the following model. The species with the least
rhombic character (g = 4.08, 4.02) is assigned to hydroxylase having no bound
protein B. When protein B binds to this enzyme, the active site environment is
altered, and the {Fe(NO)}7 unit assumes a slightly more rhombic coordination
environment. This species is assigned to the g = 4.15, 3.95 signal. When a second
molecule of protein B is bound, the iron site rhombicity is shifted even further,
resulting in the observation of yet a third signal. Although interesting, this
information is of limited value, for it is impossible to assign specific structures to
the EPR observed species, and it is unlikely that the hydroxylase sites housing
the {Fe(NO)}7 centers have the native conformation.
Comparison Between the Reactions of the sMMO Hydroxylase with NO and 02.
The reaction of reduced hydroxylase with dioxygen in the absence of protein B
has not been investigated in detail. Under these conditions, the consumption of
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electrons and dioxygen is completely uncoupled from substrate hydroxylation
(14), although the hydroxylase does become oxidized. Intermediates Hperoxo and
Q do not accumulate. By contrast, the reaction of Hred and two equiv of protein B
with 02 has been well characterized (7, 11). The first step is the formation of the
Hperoxo intermediate, which is most likely a (g-1,2-peroxo)diiron(III) species.
Further reaction produces intermediate Q, which oxidizes substrate. There are
clear differences between the reactions with and without the presence of protein
B.
The reaction of Hred with NO to form the Hperoxo analogue Hdinitrosy,
however, occurs whether or not protein B is present. There are two possible
models to explain this difference. If the binding of protein B to the hydroxylase
modulates the iron-iron distance, in the absence of this component the iron
atoms may not have the correct separation to accommodate a peroxide-bridged
structure. If dioxygen were to bind under such circumstances, it might be
reduced to the superoxo level but not react further without being released from
iron. The binding of protein B might bring the iron atoms to the proper distance
to support 1,2-peroxo bridge formation. With NO as the reactant, the iron-iron
distance should not be an issue, and a dinitrosyl species should form whether or
not protein B is present. In the second model, protein B adjusts the relative
orientations of the available coordination sites in Hred- Without protein B present,
the coordination sites may be positioned such that peroxide cannot bridge.
Binding of protein B may cause a shift of the ligands such that the available
coordination sites are oriented to facilitate formation of a peroxide bridge. Such
shifting would not be required for NO binding to the two iron atoms. These two
models are not mutually exclusive.
The available crystallographic data for reduced sMMO hydroxylase (35)
are consistent with aspects of both models, as illustrated in Figure 10. The iron-
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iron distance in the diiron(II) center is 3.28 A, shorter than the 4.0 A distance in a
crystallographically characterized g-1,2-peroxodiiron(II) model complex having
the same M6ssbauer parameters as Hperoxo (8). Moreover, there are two sites in
the reduced diiron center structure that are occupied by very weakly bound
water molecules, and are therefore available for exogenous ligand binding. These
sites are approximately 800, or gauche, to one another when viewed down the
iron-iron axis, as illustrated in Figure 10. Binding of protein B may shift the
coordination environment so as to bring these open coordination sites into a
more eclipsed conformation and possibly also to alter the iron-iron distance. In
Figure 11, this model is elaborated by hypothesizing that Glu243 undergoes a
carboxylate shift, bridging the two iron atoms in a g-1,2 fashion, as previously
hypothesized (35). The resulting diiron environment is very much like that in the
ribonucleotide reductase R2red structure (36), where the available coordination
sites are adjacent to one another. Details of this model may be altered when
information about the structure of the complex between the hydroxylase and
protein becomes available.
Buildup of Hdinitrosyl. The formation of Hdinitrosyl from the reaction of Hred
with NO in the absence of protein B and methane is clearly biphasic. There are
several possible interpretations of this result. The first is that the initial
intermediate formed is a mononitrosyl species, with an NO molecule bound to
one of the iron atoms. Reaction with a second NO would lead to formation of
Hdiritrosyl. This hypothesis is not consistent with the available data, however.
Such a mononitrosyl species would be expected to have spectroscopic properties
very similar to those of the hemerythrin nitrosyl adduct. The ferrous iron and
resulting {Fe(NO)}7 center would couple antiferromagnetically, forming an S =
1/2 paramagnetic species that would be clearly visible by EPR spectroscopy in
rapid freeze quench samples. No such signal was apparent. Moreover, the optical
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spectrum of the intermediate revealed by global analysis of the stopped flow
data closely resembles that of Hdinitosy. A mononitrosyl species would be
expected to have a much smaller extinction coefficient.
The preferred explanation is that the initial reaction of the reduced diiron
center with NO affords a dinitrosyl intermediate, designated [Hdinitrosy1]*, which
spontaneously rearranges to the final, Hdinitrosyli, form. Since the spectra of both
species are nearly identical, they most likely have similar structures. It may be
that the [Hdinitrosy1]* to Hdinitrosyl transition is the result of a shift in the relative
positions of the NO ligands, such as that drawn in Figure 11. Another possibility
is that the iron ligand environments are largely unchanged, but that formation of
the initial [HdinitrosyI* species triggers a conformational change in the
hydroxylase, producing Hdinitrosyl, which can be resolved kinetically.
The absence of an mononitrosyl intermediate in the reaction of NO with
the reduced hydroxylase suggests a mechanism for the dioxygen reaction. This
observation means that there is a readily available coordination site on each iron
in the diiron active site that can quickly react with NO, resulting in the formation
of the diiron dinitrosyl species without formation of a diiron mononitrosyl
intermediate. This implies that the dioxygen reaction will proceed similarly, with
near-simultaneous reaction of both oxygen atoms with the two iron atoms,
respectively. This rules out a hemerythrin-type mechanism, where dioxygen
binds to just one iron and is reduced to peroxide without coordination to the
second iron.
When the Hred+NO reaction is performed in the presence of protein B the
kinetics of buildup become monophasic; no [Hdinitrosy]* intermediate is observed.
This observation can be interpreted in terms of the ligand rearrangement model
(Figure 11). If the [Hdinitrosyl]* to Hdinitrosyl transition as observed in reactions
without protein B is due to a shift in NO ligands from gauche to eclipsed
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conformations, the shift to monophasic kinetics upon addition of protein B is a
reasonable consequence of that model.
The pseudo-first-order rate constant for reaction of NO with Hred+ 2B to
form Hdinitrosy, at 4 *C is -26 s-1. This value is nearly identical to the rate constant
for reaction of 02 with Hred+ 2 B to form Hperoxo at 4 *C, ~25 s-1 (6). The rate
constants for the initial reaction with NO and 02 with Hred alone cannot be
compared, since no value is available for the latter reaction. The rate constant for
initial reaction with NO (-78 s-1) is much larger than with protein B present,
however, which suggests that the corresponding reaction with dioxygen would
also be much faster.
An investigation of the Hred+NO reaction without protein B, but in the
presence of methane, revealed monophasic buildup kinetic behavior, similar to
that as observed in the presence of protein B. This result suggests that protein B
and methane gas might be able to modify the sMMO hydroxylase structure in a
similar way. For example, it may be that both protein B and methane serve to
extrude weakly bound water from the diiron center, clearing the way for
dioxygen and nitric oxide exogenous ligand binding. One of the two steps
observed kinetically in the Hred+NO stopped-flow experiments might therefore
be loss of bound water. Addition of methane or protein B would facilitate this
reaction, resulting in first-order kinetics. A similar effect is well known in the
cytochromes P-450 (37), where substrate binding to the protein facilitates loss of a
water ligand from the heme cofactor. This explanation is also consistent with the
activation parameters determined for the reactions of Hred+NO and
Hred+2B+NO, as reported in Table 3. For the reaction of NO with Hred in the
presence of protein B, a ASt value of -24.9 cal mol-1 K-1 was calculated. This
result is consistent with binding of two NO molecules to the iron center in the
transition state. The corresponding reaction of NO with Hred without protein B
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has a much less negative ASt value of -1.1 cal mol-I K-1. This value must reflect a
compensating entropic gain in the transition state during the Hdinitrosyl
formation, such as loss of water. These results support the hypothesis that
protein B serves to organize the diiron cluster for optimal reaction with
dioxygen, as shown in Figure 11. The substrate methane appears to share aspects
of this organizational capacity.
Decay Of Hdinitrosyl- The decay of the dinitrosyl species is complex and
stopped-flow data for this process could not be fit well to any single model. The
final mixture of products, as observed by M6ssbauer spectroscopy, is
heterogeneous (data not shown). In one decay pathway, nitrous oxide is
eliminated from Hdinitrosyl to afford H0 x. This reaction is supported by gas
chromatographic detection of N 20 in the headspace above the reaction mixture.
The ability of protein B to increase the amount of N 2 0 formed is consistent with
the hypothesis that, in Hdinitrosyl, the two NO molecules are oriented in positions
unfavorable for N-N bond formation. Addition of protein B could reposition the
two NO coordinated molecules towards one another, as depicted in Figure 11, to
promote ligand migration and subsequent N-N bond formation. Reductive
coupling between two metal-bound NO molecules to form N 20 is well
precedented in the literature. The dinitrosyl adduct of the ribonucleotide
reductase R2 subunit reacts in this manner (vide supra) (27). N 20 formation has
also been observed in dicopper(I) complexes (38).
A second decay pathway is suggested by the presence of the
"unidentified" species in the Mbssbauer spectra of Hred+NO reaction mixtures. A
product with a low isomer shift appears following decay of Hdinitrosyl in the
freeze-quench M6ssbauer data. This product is diamagnetic, has Mdssbauer
properties consistent with a high-valent Fe(IV) species, and may contain the
Fe(NO)2 fragment. The data are consistent with an active site having two such
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{Fe(NO)2} centers, antiferromagnetically coupled. Formation of such a species
might result from further reaction of NO with the diiron center, displacing water
or protein side chain ligands.
Comparison with the NO Reactions of the Reduced Ribonucleotide Reductase R2
Subunit and Hemerythrin. There are many similarities between the reactions of the
reduced sMMO hydroxylase and R2red with NO. The major products formed by
each enzyme are [{Fe(NO)}7]2 dinitrosyl species that model aspects of peroxo
intermediates in the two systems. These dinitrosyl intermediates are metastable.
In the R2 system, decay is slow and apparently consists only of reductive
coupling to afford R2 met and N20. The Hdinitrosyl adduct decays more rapidly,
forming a more complex mixture of products. A reductive coupling pathway to
form N 20 is apparently present, but does not account for all of the Hdinitrosyl
decay.
The minor products formed in both reactions are also similar and include
mononuclear {Fe(NO)}7 centers and unidentified diamagnetic species having
M6ssbauer parameters consistent with [{Fe(NO)2}2]. This species appears to be a
byproduct of Hdinitrosy1 decay in the sMMO system. The similarities emphasize
the close relationship between the structures and functions of these two
enzymes, which is to perform chemistry by using dioxygen as a reactant. The NO
chemistry contrasts with that of hemerythrin, which forms a relatively
homogenous and stable NO adduct. The function of hemerythrin is to bind
dioxygen reversibly, which is consistent with its reaction with NO.
The present results have been useful in suggesting specific roles for the
action of protein B in the sMMO system. Examination of the NO chemistry of
related proteins, including stearoyl A-9 desaturase (39, 40), toluene-4-
monooxygenase (41) and phenol hydroxylase (42), would be useful in
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elucidating the similarities and differences in the reactivities of this class of
proteins.
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Table 1: Spectroscopic Properties of Non-Heme Carboxylate-Bridged Diiron Nitrosyl Complexes
Sample Optical Properties: M6ssbauer Properties Reference
Xmax [nm] (E [M-1 cm-']) 8 (mm/s) AEQ (mm/s)
[Fe 2(NO)2(Et-HPTB)(OBz)]2+ 520 (395), 620 (579) 0.67 1.44 49
E. coli Ribonucleotide Reductase R2 (dinitrosyl) 450 (760), 620 (220) 0.75 -2.13, -1.73 27
P. gouldii Hemerythrin (mononitrosyl) 608 (100), 500 (700), .65 Fe(II) 25, 26
Dinitrosyl Adduct of 450 (2100), 630 (670) 0.74 1.41 34
[Fe 2(j-XDK)(g-0 2CPh)(ImH) 2(O2CPh)(MeOH)]
CY\
Table 2: M6ssbauer Properties of Species Observed in Reactions
of the Reduced sMMO Hydroxylase with Nitric Oxide
% of % of M6ssbauer Properties
Species Hrd+NO Hred+2B+NO
Reaction Reaction 8 (mm/s) AEQ (mm/s)
mononuclear {Fe(NO)}7  36 10 0.7 -1.7
mononuclear Fe(II) 6 3 0.5 0.5
Hred 8 7 1.30 2.87
Hox 6.5 38 0.49 1.12
Hdty, 6.5 23.1 0.75 1.30
"unidentified" 38 23.3 0.2 1.08
Table 3: Time-Dependent Changes in Rapid-Freeze-Quench Mdssbauer Samples of the
Reaction of Nitric Oxide with the Reduced sMMO Hydroxylase
Percentage of Species after Mixing M6ssbauer Properties
Species
61 ms 126 ms 440 ms 8 (mm/s) AEQ (mm/s)
Hred 54 57 53 1.30 2.87
H. 11 10 8 0.57 0.98
Hdt, 15 14 10 0.72 1.55
mononuclear {Fe(NO)}7  20 19 20 0.7 -1.7
"unidentified" - - 9 0.19 0.63
C:)
Table 4: Activation Parameters from Eyring Plots of the
Reaction of the Reduced Hydroxylase with Nitric Oxide
Reaction AWt ASt(kcal mol') (cal mol-' K-')
Hred+NO Reaction, Fast Phase 13.5 ± 5.6 -1.1 ± 4.5
Hr,,d+NO Reaction, Slow Phase 15.8 ± 1.3 4.3 ± 3.0
Hred+2B+NO Reaction 7.3 ± 0.8 -24.9 ± 2.4
Figure 1: Optical spectra of the nitrosyl adduct of the reduced sMMO
hydroxylase in 25 mM MOPS pH 7.0 (solid line) and the dinitrosyl adduct of
[Fe 2(g-XDK)(g-0 2CPh)(ImH) 2(O2CPh)(MeOH)] in THF (dashed line) (34).
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Figure 2: Mdssbauer spectra of 57Fe-enriched Hred+NO and Hred+ 2 B+NO.
Mbssbauer spectra of 57Fe-enriched Hred (a) and Hred in the presence of two
equiv. of protein B (b) reacted with NO for 45 min at 4 K in zero applied field.
The solid line drawn through the data represent a simulation of the species
detailed in Table 2.
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Figure 3: EPR spectra of Hred (a, b) and Hred in the presence of two equiv of
protein B (c) exposed to NO for 45 min. Spectra were obtained at 4.3-4.8 K, 100
gW and 9.41 GHz. The buffer was 25 mM MOPS, pH 7.0.
214
4.34 4.15 4.08
4.22 4.02
3.6
0 4.08 1
c. Hred+2B+NO
c. Fled+BNO
4.02
4.34
b. Hred+NO
1400 1500 1600 1700 1800 1900
4.34
a. Hred+NO
1000 1500 2000 2500 3000 3500 4000
Gauss
Figure 3
Figure 4: (a) Buildup of the optical species associated with reaction of NO with
Hred as observed by using stopped-flow spectroscopy at 4 *C. (b) Two
comparative fits of the stopped-flow data. The first graph is a fit of the data to an
A -> B buildup model and the second is a fit to an A -> B -> C buildup.
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Figure 5: Eyring plots of the fast and slow reactions of the Hred+NO Hdinitrosyl
buildup and of the Hred+2B+NO H dinitrosyl buildup.
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Figure 6: Simulation of the Hdinitrosyl formation and decay reactions by using rate
constants derived from stopped-flow data. (top) Simulation of the first 500 ms of
reaction. Also plotted is the total of the two dinitrosyl species, which corresponds
to a fit of the stopped-flow optical data. (bottom) Simulation of the reaction from
100 ms to 10 s.
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Figure 7: Time-dependent RFQ EPR spectra following the reaction of NO with
the reduced sMMO hydroxylase at 4 *C. Spectra correspond to reaction times of
28 ms, 158 ms, 1 s and 30 s. Spectra were obtained at 4.5 K, 100 gW and 9.41 GHz.
The inset is a plot of the concentration of the mononuclear {Fe(NO)}7 species as a
function of time, with the solid line showing a monophasic fit of the data.
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Figure 8: Time-dependent M6ssbauer spectra following the reaction of Hred with
NO at 4 'C. The Hred M6ssbauer spectrum has been subtracted from all time
points. The solid line through the data corresponds to simulations using
parameters listed in Table 4.
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Figure 9: Proposed mechanism for the reactions of NO with Hred-
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Figure 10: Active site structure of the reduced sMMO hydroxylase. a. Ligand
arrangement around the iron site. Note that the open coordination sites on each
iron, occupied by weakly bound water ligands. b. Newman projection viewed
down the Fe-Fe axis in the Hred active site. The positions of the open
coordination sites are shown. These figures were prepared with MolScript (44).
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Figure 11: Proposal for ligand movements in the active site of the reduced sMMO
hydroxylase induced by binding of protein B. The schematic for the Hred active
site is taken from the crystal structure of the reduced sMMOH, and the Hred+2B
active site from the crystal structure of the reduced R2 subunit.
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